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ABSTRACT

Moser, Sydney Elizabeth. M.S., Purdue University, December 2013. The Effect of
Individual Milk Proteins on Stability of Green Tea Flavan-3-ols. Major Professor: Mario
G. Ferruzzi.

While information regarding the impact of flavan-3-ol-protein interactions on
food quality attributes (flavor, texture, and physical stability) exists, insight into the
potential consequence of these interactions on bioavailability of health-promoting flavan3-ols remains unclear. The ability of nonspecific protein interactions in flavan-3-ol rich
foods and beverages to alter digestive stability and/or digestive release (bioaccessibility)
of flavan-3-ols has been previously proposed but unconfirmed. The primary objective of
this study was to characterize effects of individual milk proteins and the milk matrix on
in vitro bioaccessibility of green tea flavan-3-ols from model beverage systems. As a
secondary objective, the impact of protein gastrointestinal digestion on protein-flavan-3ol binding was assessed using fluorometry. Protein solutions containing sodium-caseinate
(S-CSN), α-lactalbumin (α-LA), β-lactoglobulin (β-LG) (0.356 mg/100 mL, 0.01 mg/100
mL, 0.035 mg/100 mL, respectively), or non-fat dry milk (NFDM, 0.1 mg/mL) were
prepared in Jenness Koops buffer containing milk salts or dd water and formulated at
dosages of 10, 20, and 40% (v/v) into model green tea beverages containing 60 mg/100
mL total flavan-3-ols. Samples were then subjected to in vitro digestion simulating

xii
human gastric and small intestinal conditions. Pre- and post-digestion flavan-3-ol profiles
were assessed by HPLC and relative (%) and absolute (μmol/g) bioaccessibility of
individual flavan-3-ols were calculated. With regards to green tea beverages formulated
to 40% with milk protein solutions, inclusion of S-CSN significantly decreased (p<0.05)
bioaccessibility of all flavan-3-ols, β-LG significantly decreased (p<0.05) bioaccessibility
of all flavan-3-ols except EGC, and α-LA significantly decreased (p<0.05)
bioaccessibility of only gallated catechins compared to buffer controls. Furthermore, SCSN effects on flavan-3-ol absolute bioaccessibility were more notable compared to
whey proteins, decreasing bioaccessibility of EGC, EC, EGCG, and ECG from
98.29±9.22, 30.88±0.52, 40.52±1.16, and 6.51±0.16 μmol/g, respectively, from JK buffer
control to 17.82±4.68, 21.72±1.23, 11.29±1.18, and 2.86±1.20 μmol/g, respectively.
Interestingly, milk minerals from JK buffer increased flavan-3-ol stability during
digestion compared to water control, significantly increasing (p<0.05) absolute and, by
extension, relative bioaccessibility from 18 to 32%.While some individual trends were
exhibited, no overall significant dose-dependent effects (p>0.05) were observed at protein
and JK levels tested. SDS-PAGE results demonstrated only partial digestion of protein
after peptic digestion, and degradation of proteins to <10 kDa after only 15 minutes of
duodenal digestion. These results compared well with fluorometry results suggesting that
maximum binding of S-CSN by EGCG, the main flavan-3-ol in green tea, occurs when
protein is partially digested by pepsin in the gastric phase.

Further digestion by

pancreatin in the small intestinal phase appeared to reduce capacity for binding.
Combined these data suggest that interactions between individual milk proteins and
flavan-3-ols may alter bioaccessibility. However, the extent of these effects is subtle and

xiii
dependent on the ability of individual interactions to survive normal digestive conditions.
Interestingly, salts typically found in milk serum may exert protective effects on
polyphenols from tea, stabilizing them to digestive reactions that may lead to their
degradation.
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CHAPTER 1. LITERATURE REVIEW

1.1

Introduction

Both epidemiological and experimental studies support the notion that specific
plant derived polyphenols may impact chronic disease risk and health outcomes (Scalbert
& Williamson, 2000). While promising, extension of these findings to new food and
beverage systems is challenged by the poor bioavailability of polyphenols generally
reported from foods. Several factors are believed to limit polyphenol bioavailability
including digestive release from food matrices (Mandalari et al. 2013), instability to
digestive conditions (Krook et al. 2012; Bermúdez-Soto et al. 2007; Green et al., 2007;
Tagliazucchi et al. 2010), poor intestinal absorption, and rapid metabolism and clearance
(Chow et al. 2005; Lee et al. 2002). Interactions between polyphenols and specific food
components are also believed to alter stability and release of polyphenols and potentially
modulate their bioavailability (Peters et al. 2010; Green et al. 2007; Nielson et al. 2009;
Mandalari et al. 2013; Sanz & Luyten 2006). Of many potential interactions occurring in
foods, the ability of polyphenols to bind to protein and facilitate their denaturation and
precipitation has been subject of intensive investigation (Batista et al. 2009; Bohin et al.
2012; De Freitas & Mateus 2001; Pascal et al. 2007; Poncet-Legrand, 2007; Sharma et al.
2008; Soares et al. 2007; Staszewski et al. 2011; Wang et al. 2010; Yuksel et al. 2010).
While well known to contribute to the general astringent response characteristic of
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polyphenol rich foods (Siebert et al. 2011; Kennedy et al. 2006; Vidal et al. 2004;
Misnawi et al. 2004; Troszyńska et al. 2006), these interactions are believed to alter both
polyphenol and protein stability in foods and beverages, thereby affecting their
availability for chemical reactivity, subsequent digestive release/stability in the gut
(bioaccessibility) and potential for intestinal absorption and metabolism by the body
(bioavailability) (Arts et al. 2002; López de Lacey et al. 2012; Naz et al. 2011; Niseteo et
al. 2012; Serafini et al. 2003; Sharma et al. 2008).
When considering prevalence for protein-polyphenol interactions, several common
foods/beverage systems have been studied including beer and wine hazing (Gramshaw et
al. 1970; Goertges 1982; Kallithraka et al. 2011; Rinaldi 2012), grain tannins
(Emmambux & Taylor 2003; Amarowicz et al. 2005; Mullins & Lee 1991) and milk coformulated with cocoa and tea (Xie et al. 2012; Green et al. 2007; van der BurgKoorevaar et al. 2011; Reddy et al. 2005; van het Hof et al. 1998; Hollman et al. 2001;
Kyle et al. 2007; Keogh et al. 2007; Roura et al. 2007; Schramm et al. 2003; Serafini et al.
2003; Neilson et al. 2009). Of these foods, tea remains one of the most significant
dietary sources of polyphenols in the US diet (Song et al. 2008; Wang et al. 2011; Chun
et al. 2007) and its consumption has been associated with prevention and/or amelioration
of several chronic and degenerative diseases including cancer (Yuan et al. 2007; Hung et
al. 2004; Bonner et al. 2005), cardiovascular disease (Hooper et al. 2008; Zuchi et al.
2010; Steptoe et al. 2007), diabetes (van Dieren et al. 2009; Song et al. 2005) and
neurodegenerative processes (Kuriyama et al. 2006; Ng et al. 2008; Hu et al. 2007). Tea
is a rich source of flavan-3-ols or catechins, specifically epicatechin (EC),
epigallocatechin (EGC), epigallocatechin-gallate (EGCG), and epicatechin-gallate (ECG).
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Interestingly, tea is also commonly consumed with addition of protein rich milk in
Ireland, Canada, and the UK (Devine et al. 2007; Yang et al. 2000; Weisburger et al.
1997; Hertog et al.1997) and increasingly in other countries including the US. Several
studies have demonstrated the ability of flavan-3-ols to interact with individual milk
proteins, with these interactions having potential to alter their biological activities (Arts et
al. 2002; Lorenz et al. 2007) and bioavailability (Shpigelman et al. 2012). Hydrophobic
interactions between bovine milk proteins and polyphenols occur (Yuksel et al. 2010)
that are structurally specific and increase with galloylation (i.e. stronger for EGCG and
ECG than for EC and EGC) (Xiao et al. 2011).
Effect of milk addition to tea flavan-3-ol bioaccessibility and bioavailability has been
previously explored both in vivo and in vitro, however results to date have been
inconsistent and remain controversial. For example, addition of milk at 5.6-40% had no
affect on black tea flavan-3-ol bioaccessibility (van der Burg-Koorevaar et al. 2011),
however others have demonstrated that addition of milk between 10 and 50% impact
flavan-3-ol bioaccessibility from black and green tea in vitro (Xie et al. 2012; Green et al.
2007). However, addition of milk to black tea had no apparent affect on levels of blood
flavan-3-ol in vivo (Van het Hof et al.1998; Kyle et al. 2007). While interactions between
flavan-3-ols and protein are well documented, it is unclear the extent to which these
polyphenol-protein interactions may impact availability of flavan-3-ols for reaction and
absorption in the gut. Furthermore, information on the effect of specific milk proteins on
digestive release and stability in the gastrointestinal tract is lacking. Additional insight is
needed in order to better understand the potential physiological consequences of
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associations between individual milk proteins with flavan-3-ols in order to leverage
potential effects for optimal delivery of dietary polyphenols.
The overall objective of this thesis is to develop a more detailed understanding of
how interaction between select green tea flavan-3-ols and milk proteins can alter their
bioaccessibility from model beverage systems. The purpose of this literature review is to
characterize predominant flavan-3-ol components present in green tea, review their
associated health benefits and summarize the current state of understanding relative to
their bioavailability, metabolism and biological activity as influenced by protein.

1.2

Classification and Nomenclature of Polyphenol Compounds

Polyphenols are plant metabolites synthesized through the shikimate and acetate
pathways (Strack D. 1997). Characterized as secondary metabolites, polyphenols aid in
plant growth and reproduction as well as serve to protect the plant from pathogens and
predators. In addition, many classes of polyphenols also serve as substrates for
enzymatically driven browning reactions and can function as antioxidants in plants
(Robards et al. 1999).
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Figure 1: Major phenolic classes of plant secondary metabolites.

Over 8,000 phenolic compounds have been documented in nature (Tsao R. 2010).
The four main classes of polyphenols include phenolic acids, flavonoids, stilbenes, and
lignans (Scalbert et al. 2000) (Figure 1). Phenolic rings containing one or more hydroxyl
substituents are characteristic of most phenolic structures. Simple phenolic acids can be
divided into two main types, benzoic acid and cinnamic acid derivatives, based on C1–C6
and C3–C6 backbones. Two major phenolic acids are caffeic acid, found in fruits,
vegetables and coffee, and ferulic acid, typically found in the bran fraction of cereal grain
(Scalbert et al. 2000). Flavonoids are more complex polyphenols having a C6–C3–C6
backbone in which the two C6 units are of phenolic nature (Tsao R. 2010). Flavonoids
can be further divided into different sub-groups according to the oxidation state of the
heterocyclan pyran ring (Cheynier 2005). Major flavonoid classes include anthocyanins,
flavan-3-ols, flavones, flavanones and flavonols (Figure 2).
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Flavan-3-ols are believed to be the most abundant flavonoid found in the western diet
(Chun et al. 2007).

They are present in numerous common foods and beverages

including tea, apple, cocoa and grape derived products (Hara et al. 1995; Gu et al. 2004)
(Table 1). Flavan-3-ols are structurally characterized by a lack in each a double bond
between C2 and C3, a C4 carbonyl, and of conjugation to glycosidic moiety at C3 (as
most other classes of flavonoids naturally are). These unique structural characteristics
provide flavan-3-ols the ability to have two chiral centers and four diasteroisomers (Tsao
2010). Furthermore, monomeric catechin and epi-catechin are known to be precursours
for more complicated polymers referred to as proanthocyanidins (PACs) ranging in
degree of polymerization from DP2 to about DP30 (Takahata et al. 2001; Hayasaka et al.
2003; Hanlin et al. 2011). The eight major flavan-3-ol monomers that occur in nature and
predominate in green tea include (-)-gallocatechin-3-gallate (GCG), (-)-epigallocatechin3-gallate (EGCG), (-)-gallocatechin (GC), (-)-epigallocatechin (EGC), (+/-)-catechin (C),
(-)-epicatechin (EC), (-)-catechin-3-gallate (CG) and (-)-epicatechin-3-gallate (ECG).
The 5’ position on the B ring of EGC is a pyrogallol group, compared to the pyrocatechol
group on the same position of EC. ECG and EGCG are gallic esters of EC and EGC,
respectively, containing a gallic acid moiety at C3 (Henning et al. 2008).
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Table 1: Flavonoid content of selected foods.
Food

Number of
data points

Mean concentration (mg/100g, edible portion) +/- SEM
(-) –EC

(-) -ECG

(-) -EGC

(-) -EGCG

(+) -C

(+) -GC

Total

Apple, raw, with skin

59 – 150

7.53 ± 0.44

0.01 ± 0.00

0.26 ± 0.07

0.19 ± 0.11

1.30 ± 0.07

-

9.29 ± 0.46

Apple juice

13

4.71 ± 2.25

-

-

-

1.25 ± 0.69

-

5.96 ± 2.35

Applesauce

1

5.41 ± 5.41

-

-

-

0.69 ± 0.69

-

6.10 ± 5.45

Cocoa, dry powder

13

196.43 ± 45.38

-

-

-

64.82 ± 14.53

-

261.25 ± 47.65

Candies, chocolate, dark

5

84.40 ± 13.54

-

-

-

24.20 ± 5.74

-

108.60 ± 14.71

Candies, chocolate, milk

6 or 9

10.88 ± 2.68

-

-

-

4.16 ± 1.21

-

15.04 ± 2.94

Grapes, black

4 or 11

8.68 ± 2.48

-

-

10.14 ± 2.91

-

21.63 ± 3.82

Grape juice

25 – 28

0.54 ± 0.07

-

0.79 ± 0.09

-

1.33 ± 0.11

Grapes, white or green

7 or 14

1.70 ± 0.42

0.25 ± 0.08

0.02 ± 0.00

-

3.73 ± 0.92

0.01 ± 0.00

5.71 ± 1.01

Tea, black, brewed

55 – 94

2.13 ± 0.10

5.86 ± 0.17

8.07 ± 0.45

9.36 ± 0.46

1.51 ± 0.07

1.25 ± 0.22

28.18 ± 0.71

Tea, green, brewed

66 - 97

7.36 ± 0.31

16.39 ± 1.93

22.27 ± 0.89

64.15 ± 5.02

3.28 ± 0.88

1.54 ±

Tea, green, ready-to-drink

2

1.98 ± 0.11

0.93 ± 0.06

4.99 ± 0.53

3.96 ± 0.40

Tea, white, brewed

3

-

2.81 ± -

9.20 ±

-

19.40 ±

-

46.00 ±

-

0.02

-

114.99 ± 5.53
11.88 ± 0.68

-

-

74.60 ± 0.00

Adapted from: U.S. Department of Agriculture, Agricultural Research Service. 2011. USDA. Database for the Flavonoid Content of Selected Food.
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1.3

Polyphenol Biosynthesis

Phenylalanine, a product of the shikimate pathway is a precursor for the majority of
phenolic compounds found in plants. The biosynthesis of polyphenolic compounds is
outlined in Figure 3. General polyphenol metabolism involves conversion of
phenylalanine to p-coumaric acid (hydroxycinnamic acid). Key enzymes catalyzing this
transformation include phenylalanine ammonialyase (PAL), cinnamate 4-hydroxylase
(C4H), and hydroxycinnamate CoA ligase (CoAL). PAL catalyzes deamination of
phenylalanine to trans-cinnamic acid followed by hydroxylation and methylation
reactions

catalyzed

by

monooxygenases

to

form

hydroxycinnamates.

Hydroxycinnamate:CoA ligase or O-glucosyltransferase then activate hydroxycinnamates.
Resulting hydroxycinnamate CoAs

enter phenylpropanoid

reactions

including:

condensation with malonyl-CoA leading to flavonoids; degradation by removal of an
acetate unit resulting in hydroxybenzoates; NADPH-dependent reduction leading to
lignin precursors and hydroxycinnamyl alchohols; and conjugation through attachment to
a hydroxyl or amino-group-bearing molecule with loss of water leading to esters, amides,
or in rare cases attachment to phenolic hydroxyl groups leading to glycosides (Strack D.
1997).
Flavonoid biosynthesis is initiated by chalcone synthase, which synthesizes the basic
C15 skeleton by catalyzing condensation of 4-coumaroyl-CoA to form 2’,4,4’,6’tetrahydroxychalcone. Naringenin chalcone, possessing the characteristic B-ring of
flavonoids, is the first intermediate product. Acetyl-CoA carboxylase supplies MalonylCoA providing acetate units that randomly orient to form the flavonoid A-ring, leading
the 5-hydroxyflavonoid pathway. Flavonoids usually occur as water-soluble glycosides,
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commonly

3-O-(di)glycosides

(Strack

D.

polymethoxylated derivatives and flavan-3-ols.

1997).

Exceptions

include

some
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Ashihara et al. 2010 suggested possible biosynthetic pathways of specific flavan-3ols. Chalcone isomerase transforms naringenin-chalcone into naringenin, which is then
converted to dihydrokaempferol (DHK) by flavanone 3-hydroxylase. From here there are
two pathways that may occur: one resulting in EGC and EGCG, and the other in EC and
ECG. DHK is converted to either dihydromyricetin or dihydroquercetin by flavonoid
3’,5’-hydroxylase or flavanone 3-hydroxylase, respectively, followed by sequential
enzymatic transformations by dihydroflavanol 4-reductase (DFR), anthocyaninin
synthase (ANS), and anthocyanidin reductase (ANR). EGC results from enzymatic
transformation of dihydromyricetin, and EC from dihydroquercetin. EGC and EC may
then become esterified to gallic acid at the C3 position to form EGCG and ECG,
respectively.

1.4

Flavan-3-ols and Health

1.4.1

Cardiovascular Disease

Cardiovascular diseases (CVDs) are major contributors to fatality worldwide.
Major causes of CVDs are believed to include oxidized low density lipoprotein (LDL)
and free radical damage to the endothelium which ultimately results in inflammatory
stress and subsequent damage to endothelial structure. Stiffness and blockages may then
develop in vessels leading to increased risk for heart attacks, stroke or other forms of
coronary artery disease (Mendis et al. 2011).
Many studies have suggested a protective association between dietary polyphenol
consumption and CVD risk and outcomes. Intermediate intake (mg/day) of flavonoid
classes

including

anthocyanidins,

flavan-3-ols,

flavones,

flavonols,

and
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proanthocyanidins were associated with a lower risk of death from CVD (McCullough et
al. 2012). Furthermore, meta-analysis of randomized controlled trials indicated isoflavone
and flavan-3-ol rich foods specifically including chocolate, soy protein isolate, and green
tea significantly reduce cardiovascular risk factors (Hooper et al. 2008) and
supplementation of 200 mg/day of grape seed flavan-3-ols resulted in a significant
improvement in overall vascular health (Weseler et al. 2011). In addition, lag time in
LDL oxidation ex vivo significantly increased in healthy men consuming an equivalent of
seven to eight cups a day of green tea for two weeks (Miura et al. 2000), however
consumption of six cups of green or black tea per day for four weeks showed no effect on
LDL oxidation in vivo or ex vivo (van het Hof et al. 1997), indicating that tea flavonoids
may have more of an effect on onset than extent of LDL oxidation.
Risk of heart attack is increased by adherence and aggregation of blood platelets
to the vascular wall (Gregg & Goldschmidt-Clermont 2003). Studies suggest that flavan3-ol-rich supplements and select flavonoid rich foods may decrease platelet aggregation.
Consumption of flavan-3-ol rich dark chocolate (40 g) by heart transplant recipients
decreased platelet adhesion in correlation to increased serum epicatechin, and improved
coronary vasomotion (Flammer et al. 2007). In addition, ADP- and epinephrinestimulated platelet activity of plasma from male smokers was decreased ex vivo following
consumption of a flavan-3-ol-rich supplement (Polagruto et al. 2007).

1.4.2

Cancer

Cancer is caused by uncontrolled growth and spread of abnormal cells that often
leads to death. In 2007, the burden of direct medical costs and indirect mortality was
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about $226.8 billion and in 2008, about 12 million Americans had a history of cancer.
(American Cancer Society 2012).
Results from epidemiological studies concerning effect of flavan-3-ols on cancer
have been inconclusive for the most part. Flavan-3-ol rich green tea has been both
negatively associated (Wang et al. 2007; Hung et al. 2004) and unassociated (Wang et al.
2002) with esophageal cancer and associated both negatively (Zhong et al. 2001; Bonner
et al. 2005) and positively (Tewes et al. 1990) with lung cancer risk. Furthermore, in the
Shanghai Cohort Study EGC and its methylated metabolite, but not EC nor its
metabolites, were significantly associated with colon cancer protection in men (Yuan et
al. 2007). Confounding variables such as temperature of the tea and smoking status of
participants may complicate analysis of data in esophageal and lung cancer studies,
respectively (Gao et al. 1994; Yuan et al. 2011).

1.4.3

Diabetes

Diabetes is the 7th leading cause of death in the United States, affecting about 8.3%
of the population (Centers for Disease Control and Prevention 2011). The metabolic
disorder is characterized by hyperglycemia due to defects in insulin secretion and/or
action (American Diabetes Association2008).
Similar to studies on association of flavan-3-ol effects with cancer, studies
exploring effect of flavan-3-ol consumption on diabetes have been inconclusive. Coffee
and tea consumption (3 cups/day) reduced risk of type 2 diabetes by about 42% in one
study (van Dieren et al. 2009), however in another there was no significant association
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between diabetes risk and consumption of coffee or tea, except in subjects over 60 years
old who had lost weight (Greenberg et al. 2005).

1.4.4

Neuroprotection

Cognitive deterioration during the ageing process is a major concern. Two major
diseases characterized by cognitive decline are Alzheimer’s disease (AD) and
Parkinson’s disease (PD). One in eight Americans suffer from AD, an ailment caused by
accumulation of amyloid peptides and tau protein in brain neurons (Alzheimer’s
Association 2012). PD is a neurodegenerative disease caused by dysfunction of
dopaminergic neurons (Schapira et al. 1990; Parker et al. 2008; Keeney et al. 2006) and
affects about 1 in 100 people (Shapira 2004). Longitudinal and cross-sectional studies
found that total tea intake by Chinese, Japanese, and Finnish adults was significantly
associated with lower prevalence of cognitive decline (Ng et al. 2008; Kuriyama et al.
2006; Hu et al. 2007).
Evidence from numerous animal studies further supports that flavan-3-ols may
have neuroprotective benefits. EGCG (50 mg/kg) administered orally through drinking
water for 6 months reduced amyloid β peptides and modulated tau profiles in Alzheimer
transgenic mice (Rezai-Zadeh et al. 2008). The ability of green tea polyphenols (GTPs) to
improve stress induced cognitive impairment was studied. Male Sprague–Dawley rats
consuming ≥0.5% GTPs in their diet showed improved psychological stress-induced
cognitive function compared to controls (Chen et al. 2009). Furthermore, GTPs (150 and
450 g/day-fed, 7 days) protected dopaminergic neurons, decreased generation of reactive
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oxygen species and nitric oxide, and inhibited lipid peroxidation in Male Sprague–
Dawley rat models of PD (Guo et al. 2007).
It is important to note that results presented above have been inconsistent.
Variability in food, food component and polyphenol doses (low to high supplemental
doses) between studies may contribute to these observations. Each type of study has
potential drawbacks. In epidemiological studies, correlations, but not causation, can be
made between intake and disease. Furthermore, the complexity of the human diet makes
it difficult to isolate the health effect of individual dietary phenols (Hollman et al. 2001)
or their biologicaly relevant metabolites. Differences in agricultural practices, season,
processing, portion of food used, or amount of food or food component used all serve to
alter flavan-3-ol exposure and perhaps outcomes observed in epidemiological and
experimental settings (Clifford et al. 2004).

1.4.5

Protective Mechanisms Associated with Flavan-3-ols

Reactive oxygen, nitrogen, and halide species in amounts that overwhelm
antioxidant defense systems result in oxidative stress that lead to damage to cells and
change cell signaling pathways, initializing ageing and disease processes (Kontic-Vucinic
et al. 2008; Wang et al. 2006a; Pong 2003). The health-promoting activity most
commonly associated with flavan-3-ols has been their antioxidant activity (Halliwell et al.
2005) derived from the multi-phenolic structure that allows polyphenols to reduce
reactive oxygen species by donating an electron transforming into an aryloxyl radical
with an unpaired electron stabilized over its aromatic rings (Dangles et al 2012). These
radicals can prevent initiation of new chain reactions and can act as terminators of the

17
propagation route by reacting with other free radicals (Shahidi et al 1992). Polyphenols
can also indirectly act as antioxidants by chelation of divalent metal ions involved in prooxidative reactions including Fenton and Haber-Weiss reactions (Duthie et al 2000) or by
stimulating the body’s endogenous antioxidant systems (Li et al. 2006; Chandronitha et al.
2010; Yuan et al. 2007).
Flavan-3-ols have demonstrated the ability to regenerate endogenous antioxidants
and stimulate defense mechanisms of cells by up-regulating expression of antioxidant
enzymes (Dangles et al. 2012). As little as 0.05 μM of procyanidins from grape seed
extract enhanced endothelial NO-synthase-mediated relaxation in internal mammary
aortic rings, indicative of cardioprotective effects (Aldiniet al. 2003). In addition, a
cocao extract inhibited CYP1A activity reducing the mutagenicity of benzo[a]pyrene by
limiting its biotransformation to the ultimate carcinogenic form (Ohno et al. 2009). Apple
polyphenols including C and EC induced glutathione S-transferase, a phase II gene
involved in xenobiotic detoxification, in colon epithelial cells (Petermann et al. 2009). In
a study by Manna et al. 2009, tea polyphenols restricted benzo[a]pyrene-induced lung
carcinogenesis in mice indicated by altered expression of p53-associated genes.
Furthermore, EGCG increased protein levels of Nrf2 and mRNA levels of UGTs in nude
mice, suggesting EGCG activates the Nrf2-UGT1A pathway (Yuan et al. 2007).
Flavan-3-ols have also demonstrated the ability to modulate cell-to-cell
communication by upregulating intracellular gap junction communication. For example,
cocoa flavan-3-ols including EC and C have been shown to attenuate hydrogen peroxideinduced inhibition of gap-junctional intercellular communication (GJIC) in rat liver
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epithelial cells through antioxidant activity and direct inhibition of mitogen-activated
protein kinase (MEK) 1 activity (Lee et al. 2008).

1.5

Overview of Bioaccessibility and Bioavailability of Flavan-3-ols

While many biological activities have been proposed and explored for flavan-3ols, it is important to consider the ability of these individual species to cross the intestinal
barrier and be made availabile for tissue uptake and utilization. Therefore bioavailability
of flavan-3-ols has been increasingly a topic of focused research and subject of many
comprehensive reviews. The term bioaccessibility is used to refer to the preabsorptive/digestive release and solubilization of compounds from food matrices by
digestive enzymes or bacterial microflora present in the gut. Compounds that are stable to
gut luminal condition (e.g. enzymes, pH and oxidative environment) during digestion
(digestive stability) are described as available for subsequent absorption in the intestine
(bioaccessible) (Saura-Calixto et al. 2007) (Figure 4). The stability of flavan-3-ols during
digestion as well as their metabolism by mammalian phase I and phase II systems and
transformation by microbiota are subject of extensive reviews (Spencer et al. 2003;
Ferruzzi et al. 2012; Monagas et al. 2010). This review will primarily highlight key
aspects of oral, gastric and intestinal processing as it related to flavan-3-ol
bioaccessibility and is the focus of the research described in subsequent chapters.
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Figure 4: A schematic outlining the concept of bioaccessibility and bioavailability of
bioactive components after consumption.

1.5.1

Oral Phase

Mechanical break-down of the food matrix and enzymatic degradation of
carbohydrates by salivary α-amylase at near neutral pH occurs during the oral phase of
digestion. Flavan-3-ol-protein interactions have been well described in this phase of
digestion. Proline-rich salivary proteins have demonstrated the ability to interact with
flavan-3-ol monomers and polymers resulting in an “astringent” response (Bajec et al.
2008; Bate-Smith 1954; Lu et al. 1998). Interestingly, studies have demonstrated the
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ability of these interactions to stabilize flavan-3-ols (Tsuchiya 1997) and prevent
association of flavan-3-ols with digestive enzymes, mitigating the potential antinutritive
effect associated with complex polyphenol polymers (tannins) (Lu et al. 1998; Prinz et al.
2000) further down the GI tract. Additional modifications to flavan-3-ols during the oral
phase may include potential for degalloylation of EGCG to EGC by esterase activity in
human saliva (Yang et al. 1999). However, this notion remains controversial as the
presence of esterases in saliva remains a topic of intense debate. In general, oral
processing is not believed to induce significant changes to flavan-3-ol structure or
availability other than through interaction of free flavan-3-ols with salivary proteins.

1.5.2

Gastric Phase

Orally processed food or beverages containing flavan-3-ols is passed from the
oral cavity into the stomach where digestion of the food matrix continues in the gastric
environment. Mechanical break-down by mixing as well as initial digestion of the food
matrix by pepsin occurs at low pH during this phase. Monomeric flavan-3-ols are
generally water soluble and stable to low pH (2-4) (Spencer et al. 2000; Uzunović &
Vranić 2008), and thus begin to be extracted from the partially digested food matrix and
solubilized in the stomach during chyme formation. In vitro studies suggest that after
solubilization, flavan-3-ol polymer proanthocyanidins (PACs) may be hydrolyzed to
smaller units or monomers (Spencer et al; 2000, Kahle et al. 2011; Rios et al. 2002).
However, as with esterase activity, evidence of depolymerization of PACs in the stomach
remains limited and it is generally believed that flavan-3-ols in all forms remain generally
stable to gastric conditions (Fernández et al. 2013; Bouayed et al. 2012; Laurent et al.
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2007). While certain phenolics/polyphenols, such as anthocyanin, quercetin, chlorogenic
acid and phenolic acids, may be absorbed in the gastric environment (Passamonti et al.
2005; Konishi et al. 2006; Lafay et al. 2006; Crespy et al. 2002; Vanzo et al. 2007), most
flavonoids, including flavan-3-ols, are not absorbed in this portion of the GI tract to any
significant extent. However, proposed mechanisms for absorption of polyphenols in the
stomach include passive trans-epithelial diffusion (Tsuji et al. 1996) and carrier-mediated
trans-epithelial diffusion (Vanzo et al. 2007) as well active transport by billitranslocase
(Passamonti et al. 2002)

1.5.3

Small Intestine

Gastric chyme containing partially digested food and partially bioaccessible
flavan-3-ols is released from the stomach into the upper small intestine (duodenum) for
further digestion. Bile salts, pancreatic enzymes including lipase, trypsin, α-amylase, and
elevated pH (pH 6-7.5) (Fallingborg 1999) are characteristic of small intestinal conditions.
Flavan-3-ols appear to be susceptible to oxidative degradation at this stage of digestion,
possibly due to oxidative processes occurring in the presence of both reactive oxygen
species and elevated pH conditions (>5.5) (Yoshino et al. 1999; Zhu et al. 2002a; Green
et al. 2007; Neilson et al. 2007; Ferruzzi et al. 2010). Additionally, flavan-3-ols may
epimerize during the duodenal phase (Kahle et al. 2011) generating higher proportions of
C, GC and GCG forms from predominant epi forms in food and beverages.
Intestinal absorption of polyphenols and flavan-3-ols has been subject of
extensive reviews (Scalbert et al. 2000; Manach et al. 2004; Monagas et al. 2010). Extent
of flavan-3-ol absorption and bioavailability may differ according to stereochemistry
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(Baba et al. 2000) and galloylation (Auger et al. 2008; Stalmach et al. 2009; Stalmach et
al. 2010; Lee et al. 2002). Absorption from the small intestine is limited to flavonoid
aglycones such as flavan-3-ols and select O-β-D-glucosides (Dangles et al. 2012). O-β-Dglucosides can be hydrolyzed by lactase phlorizin hydrolase to its aglycone form and
absorbed via passive diffusion as a result of its increased lipophilicity and its proximity to
the cellular membrane (Day et al. 2000). Absorption directly through a sodium-dependent
glucose transporter (SGLT1) intact (Walgren et al. 2000; Wolffram et al. 2002) as well as
intracellular hydrolysis by cytosolic β-glucosidase have been demonstrated (Day et al.
2003). Flavan-3-ols are the flavonoids that are most commonly present as aglycosides in
the diet, therefore their monomers may be absorbed directly in the small intestine for
further metabolism by passive or carrier-mediated diffusion (Henning et al. 2008).
Enzymes active in transport of flavan-3-ols include monocarboxylate transporter (MCT)
and organic anion transport protein B (OATP-B). OATP-B is a pH dependent transporter
that aided in passive absorption of quercetin into small intestine epithelial cells in vitro
(Chabane et al. 2009). MCT1 catalyzes proton-coupled transport of flavonoids. ECG was
transported in vitro, and multiple flavonoid agylcones were transported both in vitro and
in vivo by MCT1 (Vaidyanathan & Walle 2003; Wang 2007). Generally, monomeric
flavan-3-ols reach Tmax in plasma at 1.5 hours after ingestion (Manach et al. 2005).
However flavan-3-ol oligomers and polymers with degree of polymerization over three
are not believed to be absorbed effectively and are passed to the colon where further
metabolism by colonic microbiota is possible (Manach et al. 2004; Donovan et al. 2006).
Once present in the enterocyte, various xenobiotic “Phase II” metabolizing
enzymes including uridine-5’-diphosphate glucotransferases (UGTs) present in the small
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intestine, and sulfotransferases (SULT) and catechol-O-methyltransferases (COMT), also
present in the liver, begin to biotransform flavan-3-ol aglycones to sulfate, glucuronide,
and/or methylated metabolites. These conjugated metabolites are further distributed in
circulation and can also be effluxed back into the lumen of the small intestine. UGT1 is
the enzyme considered responsible for flavonoid glucuronidation (Cheng et al. 1999).
Conjugation of EC occurs at C-3’ and C-4’ (B ring) and C-5 and C-7 (A ring) hydroxyl
groups, resulting in monoglucuronide, sulfate, methyl ester, or combined derivative forms
(Baba et al. 2000; Natsume et al. 2003; Schroeter et al. 2006). The main glucuronide
derivative of both EC and EGC is 3’-O glucuronide (Natsume et al. 2003; Li et al. 2001;
Lu et al. 2003; Urpi-Sarda et al. 2009). However, after consumption of cocoa, O-sulfated
metabolites of EC have been reported as predominant urinary metabolites (Roura et al.
2008) and following consumption of tea, EGC metabolites identified include 3’- and 7-O
glucuronides and 4’-O methyl and its derivatives (Sang et al. 2008a; Sang et al. 2008b; Li
et al 2001; Meng et al. 2002; Lu et al. 2003). EGCG metabolites were primarily
methylated on B and D rings in cytosol samples from CF-1 mice, Sprague-Dawley rat,
and human liver and in biliary fluids of Wistar rats (Lu et al. 2003; Kida et al. 2000).
Prominent EGCG metabolites found in human and rat sera include 4’,4”-di-OmethylEGCG, and 4”-O-methylEGCG (Meng et al. 2002). Interestingly, EGCG may also
reach plasma unmetabolized: it was reported as the only unmetabolized flavan-3-ol from
ready-to-drink green tea recovered in human plasma, and was present at higher
concentrations than EGC and EC metabolites (Del Rio et al. 2010).
With regards to procyanidins, dimeric procyanidins have been detected at very
low concentrations (nM range) in human plasma after consumption of cocoa and grape
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seeds (Holt et al. 2002; Sano et al. 2003). Both procyanidin dimers and trimers have also
been detected in Sprague-Dawley and Wistar rat plasma after ingestion of cocoa extracts
(Baba et al. 2002; Zhu et al. 2002b) and cocoa cream and hazelnut skin extracts (Serra et
al. 2013). Also, only native and methylated procyanidin dimer metabolites were found in
Wistar rat plasma (Shoji et al. 2006). However, in general, bioavailability of dimeric
forms was reported to be significantly lower than monomeric flavan-3-ol forms.
The adenosine triphosphate (ATP)-binding cassette (ABC) family of transporters
including multidrug resistance protein (MRP) and P-glycoprotein (P-gp) are responsible
for efflux of polyphenolic metabolites from intestinal enterocytes back to the gut lumen
thereby limiting overall trans-cellular transport and oral bioavailability of flavan-3-ols.
Metabolites that are passed to the bloodstream may undergo further metabolism in the
liver and kidney. Additionally, absorbed or hepatic metabolites may be subsequently
recycled to the small intestine via enterohepatic transport in bile (Crozier et al. 2009;
Prasain et al. 2007; Clifford et al. 2004). Overall, flavan-3-ols and their conjugated
metabolites are generally poorly absorbed in the small intestine, and as a consequence,
their concentrations in plasma rarely exceed 1 μM (Manach et al. 2005). However,
intestinal tissues do appear to be a main site for their accumulation as indicated by animal
studies (Suganuma et al. 1998; Janle et al. 2010; Swezey et al. 2003).

1.5.4

Colon

About 90-95% of ingested polyphenols reach the colon after consumption
(Clifford et al. 2004) where they are extensively metabolized by colonic microbiota
(Dangles et al. 2012). The microbiota contain glycosidases that are able to
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cleaveconjugated moieties to aglycones, which are then subjected to subsequent ring
fission and other metabolic conversion. In general these processes lead to production of
smaller molecular weight benzoic acid, hydroxycinnamate and other phenolic acid
derivatives (Crozier et al. 2009). Millimolar concentrations of benzoic acid, phenylacetic
acid, and phenylpropionic acid derivatives can result from this catabolism (Williamson &
Clifford, 2010) and have been subsequently detected in urine of animals treated with
polyphenols (Sang et al. 2008; Crozier et al. 2009).
Galloylated flavan-3-ols are catabolized first via cleavage of gallic aid, followed
by decarboxylation of gallic acid to pyrogallol (Meselhy et al. 1997; Kohri et al. 2003;
Roowi et al. 2010) and opening of the C-ring. Subsequently, conversions to γvalerolactone (Meselhy et al. 1997; Roowi et al. 2010, Groenewoud & Hundt 1984) and
valeric acid (Kohri et al. 2003) followed by transformation of valeric acid to
hydroxyphenylpropionic and hydroxybenzoic acid via β-oxidation may occur.
Catabolized flavan-3-ols are then metabolized in the liver by phase II enzymes and
subsequently eliminated in urine or feces. Interestingly, a recent study showed that after
green tea consumption, polyhydroxyphenyl-γ-valerolactones were present at 10x the
concentration in urine than any other metabolites (Sang et al. 2008).
These microbial metabolites may also be absorbed, distributed through the body
and ultimately excreted in urine at much higher quantities than the parent flavan-3-ol and
primary phase II metabolites absorbed in the small intestine (Crozier et al. 2009).
Evidence shows benzoic, salicylic, p-coumaric, and ferulic acids may be transported
actively by monocarboxylate transporter MCT1 (Tsuji et al. 1994; Takanaga et al 1994;
Konishi et al. 2003), the majority of these being subjected to mammalian conjugation by
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Phase II enzymes in the gut and liver (Clifford et al. 2004). In addition, carrier-mediated
transport was involved in absorption of ferulic acid in an in vitro model for colonic
epithelium (Poquet et al. 2008).

1.6

Food Matrix Interactions

While bioavailability of polyphenols is reported to be poor, the notion that this
limited absorption can be modulated by specific food matrix interactions has been subject
of several lines of investigation. Specifically, factors that alter stability in foods and
beverages, their digestive release and stability in the gut (bioaccessibility) or their
transport/metabolism by the gastrointestinal epithelium may all provide avenues to
positively affect flavan-3-ol bioavailability (Parada & Aguilera 2007; Neilson & Ferruzzi,
2011). While polyphenol-micronutrient and polyphenol-polyphenol interactions have
been subject of several investigations, polyphenol-polysaccharide and polyphenol-protein
interactions have also demonstrated several specific effects on polyphenol bioavailability.
Considering the focus of this thesis on flavan-3-ol-protein interactions, the influence of
these macronutrients is therefore the focus of this section.

1.6.1

Polysaccharide-Polyphenol Interactions

Phenolic and polyphenolic compounds in plants can be defined as extractable
(EPP), or non-extractable (NEPP) (Chandrasekara & Shahidi, 2011). NEPP’s mainly
form complexes with polysaccharides associated with the cell wall (Ferguson et al. 2001)
and are not directly bioavailable in the small intestine (Manach et al. 2005), but can be
released in the colon, through fermentation by microbiota and transformed into

27
absorbable metabolites. These metabolites are typically phenolic acids, such as
hydroxyphenylacetic, phenylpropionic, and phenylbutryric acids (Saura-Calixto et al.
2010a; Saura-Calixto et al. 2010; Selma et al. 2009).
While these direct, covalent interactions are well known to limit availability of
phenolics, other associations with plant cell walls and polysaccharides may serve to limit
bioaccessibility of polyphenols in the gut lumen.

For example, flavan-3-ols with a

galloyl group (such as EGC and EGCG and ECG) are more able to interact noncovalently with β-glucan fibers than those without (Gao et al. 2012). Additionally,
anthocyanins, which are charged species, have been reported to interact with plant cell
wall polysaccharides including pectin and lignins after ingestion, likely facilitating their
transport to the colon and limiting their absorption in the stomach and small intestine
(Padayachee et al. 2012). As such, the majority of anthocyanins only become
bioavailable following colonic digestion which includes microbial fermentation of plant
polysaccharides and metabolism of flavonoid backbones (Williamson & Clifford, 2010).
In addition to effects of polyphenols in complexation with cell wall material on
polyphenol bioavailability, effects related to polyphenol bioactivity have been shown. In
a study by Jacob et al. 2008, twenty-five percent of polyphenols from a grape juice
concentrate were nondialyzable. These complexes had different anthocyanin conjugates
and exhibited reduced radical scavenging activity compared to dialyzate, possibly due to
differences in anthocyanin composition and to complex formation. However, nonextractable procyanidins in fruit showed positive correlations with bile acid binding,
which has been implicated in lowering cholesterol (Rideout et al. 2008), and radical
scavenging

activities

(Hamauzu

&

Mizuno

2011).

Polysaccharide-polyphenol

28
interactions may also compete with and thus inhibit interactions between polyphenols and
digestive enzymes in the gut lumen. For example, polysaccharides (arabic gum, βcyclodextrin, and pectins) reduced polyphenol interactions with α-amylase (Soares et al.
2009), an interaction associated with harmful effects such as decrease in body weight
gain (Griffiths et al. 1986).
Finally, presence of digestible carbohydrate (starch or sugars) appears to
positively influence intestinal uptake and transport of select polyphenols. Uptake of
monomeric procyanidins from grape seed procyanidin extracts (300 mg) was enhanced
by co-ingestion of a carbohydrate-rich food (600 mg; containing hydrolyzed wheat,
wheat, barley, maize, and oats) (Serra et al. 2010). A similar positive effect of
carbohydrate on flavan-3-ol absorption was noted in both animal and human clinical
studies on tea (Peters et al. 2010) and cocoa (Schramm et al. 2003; Nielson et al. 2009;
2010). However, Maillard reaction products slightly reduced chlorogenic acid absorption
(Dupas et al. 2006a). The ability of non-digestible carbohydrates to both associate and
limit bioaccessibility of and digestible carbohydrate to potentiate absorption of flavan-3ols further complicates the design and interpretation of many bioavailability studies. This
may be due in part, to direct effects to GI motility, or by association with carbohydrateflavan-3-ol transporters including SGLUT1, GLUT2 and MCT. However, the extent to
which this may actually be the case remains to be assessed.
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1.6.2

Protein-Polyphenol Interactions

1.6.2.1 Mechanisms and Factors Affecting Interactions
Polyphenols have been reported to bind to several biologically relevant proteins
including common food proteins (milk, soy and cereal), proline rich salivary proteins,
digestive enzymes, and plasma proteins. These interactions are believed to potentially
influence biological activities and bioavailability of polyphenols. As such, it is not
surprising that the mechanims of these interactions have been subject of several studies.
Examples of types and strengths of specific interactions between select proteins and
polyphenols are summarized in Table 2. Central to these interactions is hydrophobic
stacking of aromatic amino acid side chains within protein to those of dipoles within
polyphenols generated by London forces (Yuksel et al. 2010). Combined with hydrogen
bonding interaction of hydroxyl groups of polyphenols with protein chains these forces
have been reported to be major driver of such interactions. Both of these interactions
may induce changes in protein structure, depending on the protein involved (Hagerman et
al. 2012).
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Table 2: Binding kinetics and mechanisms of protein-(poly)phenol interactions.
Protein

α-casein

β-casein

β-lactoglobulin

α-amylase

BSA

Polyphenol

pH

Binding Affinity (K)

(+)-C

7.4

1.8x103M-1

(-)-EC

7.4

1.8x103M-1
3

-1

(-)-EGC

7.4

2.4x10 M

(-)-EGCG

7.4

7.4x103M-1

(+)-C

7.4

2.9x103M-1

(-)-EC

7.4

2.5x103M-1

(-)-EGC

7.4

3.5x103M-1

(-)-EGCG

7.4

1.59x104M-1

(+)-C

7.4

2.2x103M-1

(-)-EC

7.4

3.2x103M-1
4

-1

(-)-EGC

7.4

1.1x10 M

(-)-EGCG

7.4

1.3x104M-1

(+)-C

5

1.4x104M-1

(-)-ECG

5

2.0x104M-1

procyanidin B2
gallate

5

2.2x104M-1

procyanidin B4

5

1.4x104M-1

(+)-C

5

0.9x104M-1

malvidin-3glucoside

5

1.1x10 M

chlorogenic acid

7

4.5x103M-1

4

-1

11S protein
chlorogenic acid

5.5

3

3.8x10 M

-1

Binding Mechanism

Reference

Primarily London
dispersion forces,
some hydrogenbonding

Hasni et al.
2011

Primarily London
dispersion forces,
some hydrogenbonding

Hasni et al.
2011

London dispersion
forces, hydrogenbonding

Kanakis et al.
2011

London dispersion
forces, hydrogenbonding

Soares et al.
2007

Polyphenol
interactions through
London dispersion
forces with
hydrophobic pockets
and hydrophilic
surface of protein

Soares et al.
2011

Hydrogen-bonding

Sastry & Rao
1990

Interactions involved in protein-polyphenol interactions include hydrophobic
interactions (specifically London forces), hydrogen binding, and electrostatic interactions.
Generally, hydrophobic interactions are the driving force of protein-polyphenol
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interactions, while hydrogen bonds tend to stabilize interactions (Murray et al. 1994;
Papadopoulou et al. 2005; Xu and Chen 2011; Prigent et al. 2003; Jöbstl et al. 2006). For
those polyphenols that are elongated and less hydrophobic, hydrogen bonding forces are
more important than hydrophobic interactions, while compact hydrophobic polyphenols
primarily interact with proteins through hydrophobic interactions (Hagerman et al. 1998).
There have been less reports of involvement of electrostatic interactions in formation of
protein-polyphenol complexes, however evidence exists that showssuch interactions may
play a key role (Xu & Chen 2011).
Structural characteristics of polyphenols impact their affinity to bind protein.
Binding appears to increase with polyphenol molecular weight, due to presence of
aromatic rings that increase hydrophobicity and binding (Soares et al. 2007; Baxter et al.
1997; de Freitas et al. 2001). Large polyphenols may interact with proteins through
multidentate association (Baxter et al. 1997; Charlton et al. 2002; de Freitas et al. 2001;
Jöbstl et al. 2006). Alternatively, they may have low conformational mobility and thus
low binding affinity for proteins (Soares et al. 2007; de Freitas et al. 2001; Baxter et al.
1997).
Substitution pattern on the polyphenol structure may also impact affinity for
protein. For example, polyphenol galloylation increases binding interactions by initiating
binding to either several sites on the same protein or in different protein molecules
through hydrophobic effects and hydrogen binding (de Freitas et al. 2001; Baxter et al.
1997; Xiao et al. 2011; Xu & Chen 2011; Soares et al. 2007). Binding is also improved
with increased hydroxylation. Specifically, hydroxyl groups on A and B rings of flavones
and flavonols slightly enhanced interactions, hydroxyl groups on A rings of flavanones
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significantly improved interactions (Xiao et al. 2011; Xu & Chen 2011), and presence of
ortho phenolic hydroxyl groups appeared to increase interactions (de Freitas et al. 2001).
Studies have also shown that structural characteristics of polyphenols that tend to
decrease their affinity to protein include methylation, methoxylation, glycosylation, and
hydrogenation of C2=C3 double bond (Xiao et al. 2011; Xu & Chen 2011; Papadopoulou
et al. 2005).
Protein structure also influences formation of protein-polyphenol interactions.
Studies show that proline residues on proteins are important for polyphenol binding, and
proline residues followed by prolines are geometrically preferred polyphenol binding
sites. Phenylalanine is another important amino acid that promotes interactions, although
it is usually buried due to its hydrophobic nature. Histadine has been shown to be both
important and unimportant in protein-polyphenol interactions (Yan et al. 1995; Naurato et
al. 1999; Charlton et al 2002). Finally, arginine does not independently interact with
polyphenols, however it appears to be associated with strengthening interactions (Baxter
et al. 1997; Charlton et al. 2002; Soares et al. 2007).
As discussed, flavonoid interactions are typically within hydrophobic pockets and
to hydrophobic residues of proteins (Papadopoulou et al. 2005; Soares et al. 2007). The
size of the protein’s hydrophobic cavity may thus dictate types of polyphenols the protein
can interact with (Soares et al. 2007). Extent of protein secondary structure may therefore
also dictate protein binding potential and potential sites. For example, globular proteins
generally lack proline on their surface, whereas randomly coiled proteins have an
abundance of proline residues on their surface and active for binding (de Freitas et al.
2001).

33
Stacking interactions between aromatic functions are also frequently involved in
protein-polyphenol interactions (Baxter et al. 1997; Murray et al. 1994). The mechanism
for binding between EGCG and proline-rich proteins has been investigated. The major
conformation between proline-rich proteins and EGCG is the A ring over Pro5, D ring
over Pro4, and B ring close to Arg (Charlton et al. 2002). Furthermore, changes in protein
secondary structure due to protein-polyphenol interaction have been observed (Kanakis et
al. 2011; Hasni et al. 2011).
Polyphenol-protein interactions are also dependent on several factors including
polyphenol/protein ratio (Pascal et al. 2007), pH, temperature, and ionic strength in the
context of solutions (Wang et al. 2010; von Staszewski et al. 2011, 2011b). Increasing
both solution temperature and ionic strength promoted hydrophobic interactions between
polyphenol and protein (Wang et al. 2010). Increasing ionic strength increased proteinpolyphenol interactions by increasing electrostatic repulsions between protein/peptides,
decreasing protein-protein interactions that occur at the protein’s isoelectric point (pI).

1.6.2.1.1 Mechanisms and Factors Affecting Flavan-3-ol Protein Interactions

With specific regards to flavan-3-ols, interactions depend on structure of both

flavan-3-ol and protein. For example, proteins with higher proline content favor
polyphenol binding, and gallation of flavan-3-ols (EGC, EGCG, ECG, CG, GCG, GC)
increases affinity of the compound to protein (Poncet-Legrand et al. 2007). Furthermore,
size of the protein’s hydrophobic cavity affects its interactions with flavan-3-ols: bovine
serum albumin contains a large hydrophobic cavity favoring interactions with larger
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gallated flavan-3-ols, whereas human salivary α-amylase has a multi-domain structure
with small cavities optimal for binding small phenolics/polyphenols, such as gallic acid
(Soares et al 2007).
Considering the common addition of milk to tea, it is no surprise that the
interaction between tea flavan-3-ols and milk proteins has been explored. The primary
interactions involved in complexation of flavan-3-ols and proteins were reported to be
hydrophobic associations between flavan-3-ol rings and hydrophobic pockets of α- and
β- casein and β-lactoglobulin. Hydrogen bonding interactions are believed to be involved
in stabilization of these complexes. Binding of flavan-3-ols to caseins and β-lactoglobulin
occurred primarily on the surface and within hydrophobic pockets of the protein,
respectively. Increased polyphenol concentration decreased casein secondary structure
leading to protein unfolding, but altered β-lactoglobulin secondary structure leading to
stabilizion of protein structure under experimental conditions (Hasni et al. 2011; Kanakis
et al. 2011).

1.6.2.2 Impact of Polyphenol-Protein Interactions on Food Quality
Effect of protein interactions with flavan-3-ols in complex foods has been a topic
of several studies due, in part, to potential for the interactions to alter protein physical
stability, product quality and also flavan-3-ol stability/activity. This has been most
important with regards to beverage quality with specific respect to haze in juice, wine,
and beer. Haze active proteins from cereals and fruit juices are active over a wide
molecular weight range, and their ability to form complexes with polyphenols increases
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by virtue of their proline content (Asano et al. 1982). Simple phenols and polyphenol
monomers generally are not associated with haze (Asano et al. 1984). However larger
flavan-3-ol dimers and polymers have haze activity that increases with polymerization
(Mulkay & Jerumanis, 1983). Most haze is accentuated at lower temperatures that favor
formation of hydrophobic and specific electrostatic interactions. These interactions are
reversible and visually apparent haze can be reduced or eliminated when the beverage is
warmed (Asano et al. 1982). Haze may also be prevented by prohibiting presence of
oxygen from the system (Wall et al. 1996) and decreasing oxidation and polymerization
of polyphenols. It may be reduced by adsorption of haze active proteins and polyphenols
(Siebert and Lynn 1997a,b,c; 1998) and by utilization of enzymatic hydrolysis of haze
active protein (de Clerck et al. 1969).
Impacts of polyphenol interactions with dairy protein on beverage nutrition and
quality attributes have increasingly been studied due to common formulation of tea and
cocoa with milk (Table 3). Potential for both interaction and oxidative processes in these
systems creates a beverage matrix that does not favor delivery of flavan-3-ols. For
example, addition of as little as 5% milk to tea was reported to decrease antioxidant
activity of flavan-3-ol rich tea solutions as measured using both azinobis (3ethylbenzothiazoline-6-sulfonate) diammonium salt (ABTS+) and voltammetry assays.
This may have been due, in part, to binding and eventual precipitation of proteinpolyphenol complexes thereby decreasing the amount of polyphenols available to react
with oxidants in solution. A pronounced effect was observed in English breakfast tea
models compared to Darjeeling and green teas, possibly due to presence of condensed
flavan-3-ol polymers including theaflavins and thearubigins known to bind proteins to a
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larger extent than flavan-3-ol monomers (Dubeau et al. 2010). The extent to which this
effect was due to binding or a combination of binding and oxidative damage to
polyphenols at elevated pH is not known. Conversely, the same study reported that tea
antioxidant activity was increased in a lipid emulsion system, conceivably due to a
synergistic effect between milk and tea polyphenols resulting from either facilitated
deprotonation of polyphenols or creation of a physical protective barrier to lipid micelles.

Table 3: Impact of milk addition on antioxidant capacity of phenolic and polyphenolic
rich beverages.
Beverage

Main phenolic class

Antioxidant Capacity

Reference

Coffee

Flavan-3-ols, Phenolic acids

Decreased; No effect

Niseteo; Dupas et al. 2006b

Tea

Flavan-3-ols

Decreased

Dubeau et al. 2010

Cocoa

Flavan-3-ols, Phenolic acids

Decreased

Belscak et al. 2009

Black tea

Monomeric and Polymeric
Flavan-3-ols

Increased

Sharma et al. 2008

A study by Sharma et al. 2008 also produced results that initially appear
conflicting. Formulation of milk (40%) to black tea decreased total free polyphenols and
radical scavenging capacity measured using the 1,1-diphenyl-3-picrylhydrazyl (DDPH)
model. This effect was presumably due to non-covalent interactions between polyphenol
and protein. However, addition of milk, sugar, and their combination increased
antioxidant activity in a β-carotene-linoleic acid model system. Antioxidant activity may
have been more prevalent in the linoleic acid system compared to the DDPH model
because many antioxidants are highly reactive to peroxyl radicals produced during lipid
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peroxidation, but have low reactivity with the nitrogen radical in the DDPH model
(Huang et al. 2005). These confounding effects make it difficult to fully interpret impact
of flavan-3-ol-protein interactions.
Apparent masking of flavan-3-ol antioxidant capacity by milk proteins depends
on structure of both protein and flavan-3-ols and follows typical binding parameters
previously described. For example, Arts et al. 2002 concluded that a C3 gallate group
increases extent of interaction between flavonoids and milk protein, while a 5’OH group
decreases interaction. They also showed that proteins high in proline are likely to interact
with hydroxyl groups of flavonoids. For example, the greatest antioxidant masking of
EGCG (bearing a gallate group at the 3 position on C ring) and gallic acid occurred in
combination with β-casein (a protein high in proline). In a similar study, precipitation of
polyphenols by whey proteins from whey protein concentrate increased with green tea
gallic acid equivalents, and antimicrobial activity decreased with protein concentration
(von Staszewski et al. 2011b). This presumably indicates a decreased availability of
bioactive flavan-3-ols for reactivity.
Additionally, salt concentration may have an impact on protein-polyphenol
interactions. Whey protein concentrates with higher salt concentration (indicated by ash
content) bound less effectively compared to those with lower salt concentration due to a
‘screening’ effect (von Staszewski et al. 2011b). Divalent cations including iron, copper,
calcium, and magnesium may interact with electron dense phenolic rings of flavan-3-ols
rendering them unavailable for participation in flavan-3-ol-protein interactions. Many
studies have also demonstrated interactions between catechols and flavonoids with
divalent metals (Kostyuk et al. 2004; Yamada et al. 2007; Vitali et al. 2008; Al-Numair
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2009). Suggested mechanisms include chelation of salts by either two hydroxyl groups
within catechols or by formation of salt bridges between multiple catechols (Yamada et al.
2007). These interactions have several effects on flavonoid stability and chromophore
(Vitali et al. 2008; Al-Numair 2009; Mori et al. 2006; Lee et al. 2005) suggesting they
may also modulate the ability of individual flavonoids to interact with proteins.

1.6.2.3 Impact of Polyphenol-Protein Interactions of on Polyphenol Bioavailability
Digestion and absorption of polyphenols have been previously discussed.
Potential impact and interaction sites between protein and polyphenol are further outlined
in Figure 5. It is clear that co-consumed proteins and polyphenols may interact
throughout the digestive process. In fact potential impact of polyphenol-protein
interactions on bioaccessibility and bioavailability of flavan-3-ols has been previously
studied both in vivo and in vitro. Similar to effects on antioxidant activity and product
quality, there have been many conflicting results (Tables 4 and 5, respectively).
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Figure 5: A schematic outlining bioavailability and bioaccessibility of proteins and
polyphenols. Interactions between polyphenols and proteins/peptides may occur during
digestion, altering polyphenol bioavailability.
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Table 4: Impact of milk addition on in vivo bioavailability of polyphenols from foods and
beverages in humans.
Food/Beverage

Polyphenol
Analyzed

Flavan-3-ol
Content

Milk
Protein
Content

Bioavailability

Boiled

Black tea

Total flavan-3-ol

196-203mg

2.3g

Yes; plasma AUC
decreased from 1.14 to
0.95μmol/l over 3
hours

Yes

Reddy et al.
2005

0.9g, 0.3g in green
and
black tea,
respectively

3.3g

No affect on plasma
AUC over 8 hours

No

van het Hof et
al. 1998

~20mg flavonol in
both types tea

3.9g

No affect on plasma
AUC over 2 hours

Yes

Hollman et al.
2001

Yes

Kyle et al.
2007

No

Keogh et al.
2007

No

Roura et al.
2007

No

Schramm et
al. 2003

No

Serafini et al.
2003

No

Neilson et al.
2009

No

Serafini et al.
2009

Green tea, black
Total flavan-3-ol
tea
Black tea, green
tea
Black tea

Quercetin,
kaempferol

Total flavan-3-ol 395umol flavan-3-ol

Cocoa
(beverage)

C, (-) EC

2.0 - 2.7g
polyphenol

Cocoa
(beverage)

EC-glucuronide

64mg polyphenols

Cocoa
(beverage)

(-)EC, flavan-3-ol

1.5mg/kg body
weight
(about 100mg)

Cocoa (solid)

(-)EC

Not specified

Cocoa (solid)

(-)EC

36mg

Blueberry fruit

Caffeic acid,
ferulic acid

250mg polyphenol

No affect on plasma
concentration (μmol)
over 3 hours
No affect on plasma
2.45g
concentration (μmol/l)
over 6 hours
No affect on plasma
concentration (nmol/l)
8.1g
in after 2 hours
No affect on plasma
260mg/kg
Cmax or AUC over 8
(17.4g)
hours
Yes; decreased plasma
AUC by 46% over 4
hours when cocoa
6.5g
consumed with milk,
and 69% when solid
cocoa contained milk
No affect on Cmax or
Tmax over 6 hours by
8.1g
addition of milk
protein to solid cocoa
formulation
Yes; plasma AUC
decreased by 49.7 and
19.8%, respectively,
6.5g
over 5 hours by
consumption of
blueberry with milk
3.3g

Reference

Several human studies have directly investigated the impact of milk on absorption
of flavan-3-ols from tea (Table 4). Plasma flavan-3-ol concentration was higher in human
subjects that ingested tea without milk compared to with milk (Reddy et al. 2005).
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However, in contrast, bioavailability of flavan-3-ols from both green tea (van het Hof et
al. 1998) and black tea (van het Hof et al. 1998; Kyle et al. 2007) were not affected by
formulation with milk (17 and 25%) in healthy human subjects. Similarly, impact of
green tea temperature on flavan-3-ol bioaccessibility from tea beverages formulated with
and without milk was investigated with conflicting results (Table 5). Boiling green tea
beverages enhanced in vitro bioaccessibility, and addition of milk to heated beverages
decreased digestive recovery of flavan-3-ols to a greater extent compared to matching
solutions at ambient temperature (Xie et al. 2012). This result may suggest increased
protein-polyphenol interactions at elevated temperature. This effect may be due to
increased exposure of surface hydrophobic residues on protein due to its denaturation,
increasing its ability to interact with polyphenols through London forces. However, no
apparent temperature-related trend for protein-polyphenol interactions is obvious when
comparing across tea consumption and bioaccessbility studies (Tables 4 and 5).

Table 5: Impact of milk addition on in vitro bioaccessibility of polyphenols from foods
and beverages.
Beverage

Polyphenol
Analyzed

Flavan-3-ol
Concentration

Milk
Affect
Concentration Bioaccessibility

Boiled

Reference

Green tea
extract

EGC, EC, EGCG,
GCG, ECG

75 mg/mL

10 or 25% v/v

Yes

Yes, No

Xie et al. 2012

Green tea

EGC, EC, EGCG,
ECG

60mg/mL

10, 20, 50% v/v

Yes

Yes

Green et al. 2007

Black tea

Total flavan-3-ols

1.8 mol/L

5.6-40%

No

Yes

van der BurgKoorevaar et al.
2011
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Similarly to studies with tea, bioavailability of flavan-3-ols from cocoa has also
been studied with mixed findings (Table 4). Formulation of cocoa beverages with milk
had no effect on plasma concentration of C, (-)-EC, and EC-glucuronide compared to
controls (Keogh et al. 2007; Schramm et al. 2003; Roura et al. 2007). Conversely, in vivo
bioavailability of (-)-EC from solid cocoa decreased to a significant extent in a study by
Serafini et al. 2003, and modestly in another study (Neilson et al. 2009). Discrepancy in
results between beverages and confections suggest that the physical state of the food
matrix may impact protein-polyphenol binding during digestion, possibly due to affects
on gastrointestinal motility and/or rate of flavan-3-ol solubilization in the gut (Neilson et
al. 2009).
Interestingly, similar decreases in bioavailability have been observed in other
foods/beverage phenolics (Table 4). Consumption of blueberries with milk resulted in a
decrease in plasma concentrations of caffeic and ferulic acid in vivo (Serafini et al. 2009).
While milk addition to coffee did not impact bioavailability of chlorogenic acid, addition
of nondairy creamer slowed absorption (delay in Tmax) of chlorogenic acid in humans
(Reneuf et al. 2010). These data suggest that milk protein interactions with phenolics
may have diverse impact on bioavailability measures.

1.6.2.4 Impact of Polyphenol-Protein Interactions on Biological Activities in vivo
Beyond absorption, ability of flavan-3-ol-protein interactions to modulate
biological activities has been subject of several investigations (Table 6). Effect of coformulation/consumption of protein on flavan-3-olantioxidant activity was also examined
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in vivo. Addition of milk to both black and green tea did not decrease plasma antioxidant
activity in humans (Leenan et al. 2000). Similarly chlorogenic acid in coffee was bound
to dairy proteins without causing a significant effect on beverage antioxidant power.
Incidentally, interactions were found to decrease during in vitro digestion suggesting
release of phenolic compounds during normal digestion (Dupas et al. 2006a). However,
addition of milk to black tea (10%) blunted the ability of tea to improve flow mediated
dilation in humans and induce vasorelaxation in Wistar rat aortic rings (Lorenz et al
2007).
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Table 6: Impact of milk addition to beverages on bioactivity.
Model

Polyphenol
Dose/Concentration

Human, in vivo,
blueberry with
milk

250mg

Protein Dose/
Plasma
Flow
Enzyme Energy
Enzyme
Antioxidant Mediated
Gain
Activity
Concentration Capacity Dilation

Reference

6.4g

No effect

-

-

-

Serafini et al.
2009

Human, in vivo, 640 and 140 mg for
green, black tea green and black tea,
respectively
with milk

2.0g

No effect

-

-

-

Leenan et al.
2000

Human, in vivo,
black tea with
milk

450μmol

1.6g

-

Decrease

-

-

Lorenz et al.
2007

Human, in vivo,
black tea with
milk

450μmol

1.6g

-

Decrease

-

-

Lorenz et al.
2009

in vitro, green tea
polyphenols, αamylase, pepsin,
trypsin, lipase,

0.05mg/mL

6-12ug/mL

-

-

Decrease

-

He et al.
2006

in vitro, oolong
tea polyphenols,
pancreatic lipase

2.5μg/mL

12.5U/mL

-

-

Decrease

-

Nakai et al.
2005

in vitro,
flavonoids

0.05-2.3mM

3.2mg/mL
(1,500U/mg)
pepsin

-

-

Increase
initial
velocity

-

Tagliazucchi
et al. 2005

in vitro, EGCG;
α-amylase,
trypsin,
chymotrypsin

0.5mM

5, 50, and
50μg/mL,
respectively

-

-

Decrease

-

Naz et al.
2011

Mouse, in vivo,
EGCG

0.32%

-

-

-

-

Decrease

Grove et al.
2011

Rat, in vivo, tea
flavan-3-ols

1%

-

-

-

-

Decrease

Unno et al.
2009

in vivo, green tea
flavan-3-ols

199.3μmol

-

-

-

-

Decrease Wang 2006b
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Flavan-3-ol-protein interactions are believed alter macronutrient digestibility and
availability (Table 6). Addition of green tea flavan-3-ols (mostly galloylated) at 1% w/w
in diet significantly decreased body weight and increased fecal starch, protein, and lipid
excretion in Wistar rats (Unno 2009). Similarly, decreased weight gain was observed in
C57bl/6J mice fed a high fat diet formulated with 0.32% EGCG for 6 weeks compared to
those fed matching diets void of EGCG. Furthermore, EGCG significantly increased
fecal lipid content in vivo and competitively inhibited pancreatic lipase activity with 50%
inhibition at 7.5μl/l in vitro (Grove et al. 2012). These data suggest that tea flavan-3-ols
inhibit pancreatic lipase decreasing lipid absorption and concurrent weight gain. Not
surprisingly, these interactions have stimulated interest in tea flavan-3-ols as anti-obesity
agents.
Inhibition of specific digestive enzymes by flavan-3-ols has been studied
extensively (Table 6). Percent inhibition of α-amylase, pepsin, trypsin, and lipase by 0.05
mg/mL tea derived flavan-3-ols was 61, 32, 38, and 54%, respectively (He et al. 2006).
Similar results were reportedby Nakai et al. 2005 investigating effects of oolong tea
polyphenols (monomeric and polymeric flavan-3-ols) on pancreatic lipase. Inhibition by
polyphenols was attributed to presence of galloyl moieties and polymerization of flavan3-ols, suggesting direct but non-specific binding as a primary mechanism. On the other
hand, resveratrol, quercetin, EGCG, and flavan-3-ol increased initial velocity of pepsin
activity during digestion of different substrates (Tagliazuchhi et al. 2005).
There is limited information on the mechanism behind polyphenol-digestive
enzyme interactions. It appears conformational changes in digestive enzymes as a result
of polyphenol binding can reduce their catalytic activity (Bandyopadhyay et al. 2012).
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For example, binding of chlorogenic and caffeic acid to α-amylase altered the
environment of the enzyme active site, thus causing inhibition of the enzyme
(Raghavendra et al. 2007). Also, it appears that the high electron density of
flavonols/flavones compared to flavan-3-ol/flavanones increases binding to digestive
enzymes through stronger π-π interactions (Lo Piparo et al. 2008).
Interestingly, in vitro evidence suggests that the interactions of flavan-3-ols with
digestive enzymes in the gut lumen may be modified by presence of food or salivary
proteins. As described previously, proline-rich salivary proteins may also interact with
EGCG, stabilizing it to digestion and also reducing its inhibitory effect on digestive
enzymes (Naz et al. 2011). This experiment would seemingly support the notion that the
astringent response derived from polyphenol interactions with salivary proteins would
result in protection against anti-nutritional activities of polyphenols against digestive
enzymes.

1.6.3

Milk Mineral-Milk Protein and –Polyphenol Interactions

1.6.3.1 Milk Mineral-Milk Protein Interactions
Milk and its products are used as ingredients in food applications for their
nutritional and functional properties. Functional properties of milk and milk products
including gelation, viscosity, emulsification, and foaming are largely attributed to type
and amount of proteins present and interactions of proteins with milk components. Milk
minerals constitute about 8-9 g/L of milk and are present as free ions and in complexes
with macromolecules such as protein (West 1986; Lönnerdal 1988; Flynn 1992).
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Solubility of milk protein-milk mineral complexes is important for protein functionality
including properties such as emulsification, gelation and foam formation/stabilization
(Swaisgood 1992). Additionally, these interactionas are believed to impact nutritional
quality by modulating in vivo absorption and bioavailability of both proteins and minerals
(Sanyal et al. 1992; Lönnerdalet al. 1994). Impact of milk mineral interactions with
caseins and β-LG on protein structure and functionality has been subject of many reviews
(Vegarud et al. 2000; McMahon & Oommen 2008; Gaucheron 2005; Augustin 2000).
Casein micelles in bovine milk are comprised of four proteins: αs1- casein, αs2casein, β- casein, and κ-casein (Farrell et al. 2006). These caseins can interact with
themselves, each other, and with minerals (ie. ionic calcium, calcium phosphate) to form
a meta-stable supramolecular structure. Calcium bridging is an important interaction
involved in formation of casein micelles in milk. Calcium phosphate nanoclusters appear
to form interlocking sites between phosphoserine residues of multiple αs- and β-caseins,
termed “calcium bridges” (Holt et al. 1996) that provide structure-forming points for
micelle formation (Holt et al. 2003). Cation binding capacity decreases with decreased
phosphoserine content and is greatest for αs2, followed by αs1, β, and κ-casein (Holt,
1992). Following initial calcium cross-bridging, hydrophobic regions of caseins orient
toward other proteins, forming linkages through non-covalent hydrophobic and
electrostatic interactions. Further calcium bridging occurs through carboxylate and
phosphoserine side chains of other caseins (Swaisgood 2003; Sood et al. 2002). The final
casein micelle is a colloidal particle comprised of thousands of casein proteins and
hundreds of calcium phosphate nanoclusters (de Kruif & Holt 2003).
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Manipulation of minerals and mineral salts in dairy products results in altered
protein functionality that may either improve or dimish the product’s suitability for
specific food applications. For example, milk with increased soluble calcium required
increased heating time to coagulate (Kelly et al. 1982). In addition, increased calcium
concentration promoted aggregation of rennetted micelles, promoting gel formation
(Zoon et al. 1988; Udabage 1999). However, addition of calcium precipitated αs or βcasein based emulsions presumably due to shielding of casein negative charges
(Dalgleish 1987).
β-lactoglobulin is another milk protein that interacts with milk minerals. Simons
et al. 2002 investigated the mechanism behind β-lactoglobulin-milk protein interactions
through a series of tests including calcium-binding measurements, a combination of
protein chemical modifications, and aggregation studies. Interestingly, they concluded
that interactions occur due to screening of surface charges on β-lactoglobulin and
subsequent decrease in electrostatic repulsion leading to aggregation, rather than due to
formation of calcium bridges.
Many studies show that calcium enhances heat-induced aggregation of βlactoglobulin (Anema & McKenna 1996; Changani et al. 1997; Sherwin & Foegeding
1997; Xiong et al. 1993). This property is useful for gelling applications. For example,
microgels were developed by heating β-lactoglobulin witch calcium. For this application,
amount of calcium required for gel formation decreased with decreasing pH, indicating
that net charge density of the protein was crucial in microgel formation (Phan-Xuan et al.
2012). Conversely, this property causes concern in milk processing as it occurs optimally
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during high temperature short time processing, therefore causing fouling of heat
exchanges during milk processing.

1.6.3.2 Milk Mineral-Polyphenol Interactions
In addition to their interactions with proteins, many minerals in solution are well
documented to interact with flavan-3-ols in both model and complex food systems.
Mineral-flavan-3-ol interactions have been a subject of several investigations due to
concerns surrounding their impact on mineral solubility and bioavailability. For example,
the water-soluble fraction from olives contained polyphenol-bound magnesium (Yaşar &
Güçe 2004). Similarly, concentration of intact phenolic compounds recovered from
brewed herbal infusions was lower from tea infusions prepared with mineral water
containing calcium and magenesium compared to with Milli-Q-quality water and tap
water (Riehle et al. 2012), suggesting formation of mineral-flavan-3-ol complexes in
polyphenol rich beverages prepared with mineral rich water. This complex formation has
been associated with a phenomenon known as ‘tea cream’ that occurs in cooled black tea.
Tea cream has been attributed to interaction between caffeine and phenolic compounds or
self-association between phenolic compounds (Roberts et al. 1963; Jöbstl et al. 2005).
Furthermore, addition of calcium to black tea enhanced self-association of caffeine,
polyphenols, and therabugins and thus increased creaming, while addition of the
chelating agent ethylendiaminetetraacetic acid (EDTA) decreased cream formation
(Jöbstl et al. 2005; Smith 1989). Jackson and Lee 1988 discovered tannase, a polyphenol
degrading enzyme, increased solubility of iron and calcium in green, oolong, black and
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instant black tea, supporting the notion that break down of complex polyphenols would
reduce formation of mineral-polyphenol complexes. Further, calcium and magnesium
bioaccessibility from tea-biscuits was negatively correlated with polyphenol content,
suggesting formation of insoluble polyphenol-mineral complexes that survive through
simulated digestion.
Analysis of black tea stain formation on porcelain surface revealed a possible
calcium-polyphenol interaction mechanism. Polymerization of polyphenols by oxidative
reactions occurred during stain formation. Addition of calcium ions increased amount of
stain and addition of EDTA was effective in removing black tea stains suggesting that
calcium bridging between polyphenols may be involved in stain stability. Results from IR
analysis (Yamada et al. 2007) suggest that calcium complexation with polyphenols
occurs by either two hydroxyl groups within catechols or by calcium bridging formations
between multiple catechols. From these results, it appears that minerals interact strongly
with polyphenols and flavan-3-ols specifically through electrostatic interaction. There
appears to be similarity between these interactions and those with proteins in that they
have the ability to bind and form bridges between polyphenols. These similarities and
potential for competitive interactions between milk protein, minerals and flavan-3-ols, it
becomes important to consider presence and influence of milk minerals when
investigating milk protein flavan-3-ol interactions. This has not been the case in many
previous studies and has made interpretation of literature difficult. Additional insight in
these interactions is needed in order to better understand the potential impact of milk
protein-flavan-3-ol interactions in foods and beverages.
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1.7

Conclusions and Research Objectives

In summary, a growing body of evidence supports the notion that polyphenol rich
foods such as green tea can decrease risk of several chronic and degenerative diseases.
Tea derived flavan-3-ols have been reported to have modifying activities against
cardiovascular disease, cancer, diabetes, and cognitive impairment (Hooper et al. 2008;
Miura et al 2000; Weseler et al. 2011; Wang et al. 2007; Hung et al. 2004; Zhong et al.
2001; Bonner et al. 2005; Ng et al. 2008; Kuriyama et al. 2006; Hu et al. 2007). However,
bioavailability of flavan-3-ols is generally low. A key aspect of this poor bioavailability
may be related to accessibility of flavan-3-ols to intestinal tissues for absorption
(bioaccessibility).

While instability of flavan-3-ols to digestive conditions has been

previously documented to be a primary factor limiting bioavailabilitry (Yoshino et al.
1999; Zhu et al. 2002a; Green et al. 2007; Neilson et al. 2007; Ferruzzi et al. 2010), less
is known regarding the extent to which protein-flavan-3-ol interactions may alter stability
or bioaccessibility of flavan-3-ols. While a large portion of tea is currently formulated
with milk, only a few studies have evaluated effects of milk proteins on green tea flavan3-ol digestive stability and bioavailability. Interestingly, the physico-chemical nature of
flavan-3-ol-protein interactions has been subject of several investigations that have
yielded conflicting results regarding the nature and physiological consequences of such
associations. A key component to these conflicting results may involve a more detailed
consideration of the role of minerals in milk protein-flavan-3-ol interactions. Additional
insight into nature and consequences of these interactions between milk protein, milk
minerals and flavan-3-ols is required to leverage potential effects for optimal delivery of
dietary flavan-3-ols.
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The overall objective of this project is to develop a detailed understanding of the
interaction between tea flavan-3-ols, milk proteins and milk minerals in model beverage
systems. Specifically, we build on current knowledge of the nature of these interactions
by assessing in a controlled fashion the comparative binding, stability and
bioaccessibility of tea flavan-3-ols in model beverages. Our central hypothesis is that
flavan-3-ol-protein interactions will increase digestive stability and bioaccessibility of
flavan-3-ols through non-specific binding interactions with individual milk proteins in
digestive environments. We further expect that these interactions may be altered by
presence of milk minerals and that flavan-3-ol binding would modify protein digestibility
and by extension release of flavan-3-ols in the digestive environment. Understanding
how these interactions can alter digestive behavior of flavan-3-ols will lead to
development of strategies that facilitate inclusion of flavan-3-ols in food and beverage
system with improved stability and bioavailability.

To achieve our overall objectives, the following specific aims are proposed:

Specific Aim 1: Determine the impact of milk mineral and milk protein interactions
on stability of flavan-3-ols in beverage systems and in the digestive environment. A
three stage in vitro digestion model was utilized to assesss the impact of green tea
formulation with milk proteins and a milk mineral buffer solution on digestive stability of
flavan-3-ols. Our working hypothesis was that the nature of flavan-3-ol-protein
interaction will be dependent on both protein, presence of milk minerals and flavan-3-ol
chemical composition and structure. Stability would further depend on amount and type
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of proteins in the food matrix. Binding with protein would lead to enhanced oxidative
stability of flavan-3-ols through the digestive environment and thus higher digestive
recovery.

Specific Aim 2: Characterize protein profile of individual milk protein digests
resulting from in vitro digestion by pepsin and pancreatin. SDS-PAGE was utilized to
evaluate protein degradation. Our working hypothesis was that each milk protein would
be rapidly degraded due to large amount of digestive enzymes used in this study.

Specific Aim 3: Assess potential for binding between individual milk proteins
digested to various extents and intact EGCG. Fluorescence spectroscopy was utilized
to measure quenching of protein fluorescence by EGCG. Our working hypothesis was
that binding of EGCG to milk protein is altered by degradation of protein. Binding data
was used to formulate hypothesis related to in vitro digestion results.
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CHAPTER 2. MATERIALS AND METHODS

2.1

Chemicals and Standards

Acetonitrile, acetic acid, methanol, water (Mallinckrodt-Baker, Phillipsburg NJ),
and formic acid (Sigma-Aldrich St. Louis, MO) used in HPLC analysis were certified
HPLC and ACS grade. Urea (U5378), uric acid (U2625), porcine mucin (M2378), αamylase (A3176), pepsin (P7125), lipase (L3126), pancreatin (P1750), and bile salt
(B8631) extract utilized for in vitro digestion were purchased from Sigma. KH2PO4
(VWR), K2SO4 (Riedel-de Haën), potassium citrate, sodium citrate, KCl, CaCO3, and
MgCO3 (Sigma-Aldrich) used in milk salt solution (JK) (Jenness & Koops, 1962) and
Tris-HCl for fluorometry were purchased from Sigma-Aldrich. NaCl, HCl, and NaHCO3
were purchased from Mallinckrodt (Phillipsburg, NJ). Powdered green tea extract (GT)
was a gift from Nestlé PTC, Marysville, OH, USA. Acid precipitated casein was a gift
from Kerry Group (Beloit, WI) (Figure D.1), and α-lactalbumin (α-LA) and βlactoglobulin (β-LG) were purchased from Sigma. Nonfat dry milk (NFDM) was Saco
brand Mix 'n Drink. Coomassie Brilliant Blue R-250 for SDS-PAGE was purchased from
Bio-Rad. Acrylamide, sodium thiosulfate, and tetramethylethylenediamine for SDSPAGE were purchased from Sigma.
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2.2

Preparation of Protein and Oral Phase Solutions for in vitro Digestion

Buffer (JK) for protein solutions was prepared following a procedure by Jenness &
Koops, 1962. Specifically, KH2PO4, potassium citrate·H2O, sodium citrate·5H2O, K2SO4,
CaCO3, MgCO3, and KCl, were dissolved in double distilled water (dd water) and pH
adjusted to pH 6.3 with KOH to final concentrations of 1.58, 1.2, 2.12, 0.18, 1.32, 0.65,
0.3, 0.6, and 2.25 g/L KH2PO4, potassium citrate·H2O, sodium citrate·5H2O, K2SO4,
CaCl2·2H2O, MgCl2·6H2O, K2CO3, KCl, and KOH respectively. Solutions containing
individual milk proteins were formulated to mimic concentrations naturally occurring in
milk. Sodium caseinate (S-CSN) was prepared in both dd water and JK by slowly stirring
acid precipitated casein into solution for 2 hr, maintaining a pH of 6.3 by addition of 1.0
M NaOH. The final concentration of the solution was 35.6 mg/mL sodium caseinate. βLG and α-LA solutions were prepared in JK similarly; however solutions were stirred for
only 5 min. Final concentrations of β-LG and α-LA in JK were 3.5 and 1 mg/mL protein,
respectively. NFDM was prepared in dd water (10% w/w). Oral phase solution was
prepared by addition of KCl, Na3PO4, Na2SO4, NaCl, and NaHCO3 for final
concentrations of 242.78, 10.83, 8.03, 10.20, and 40.33 mmol/L, respectively.

2.3

Model Tea Beverage Preparation

GT was dissolved in dd water (3 mg/mL). The flavan-3-ol composition of the tea
powder is described in Table 7. Test solutions with tea were designed to deliver 0.60
mg/ml of total tea flavan-3-ols (0.18, 0.032, 0.33 and 0.054 mg/mL of EGC, EGCG, EC
and ECG respectively). The flavan-3-ol content was equivalent to that found in ~0.5-1
cup of tea (Bahgwat et al. 2011). Powdered tea extract solutions formulated with 10, 20,
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and 40% (v/v) of aforementioned protein solutions matching tea powder free controls (dd
water, JK) were prepared.

Table 7: Flavan-3-ol content in green tea powder.
Flavan-3-ol mg/g tea extract
powder
EGC
60.31 ± 1.29

2.4

EC

10.86 ± 0.77

EGCG

110.05 ± 2.35

ECG

17.85 ± 0.33

Three Stage in vitro Digestion of Model Tea Beverages

Aliquots of freshly prepared tea beverages were subjected to simulated oral, gastric
and small intestinal digestion in sequence as previously described by Thakker et al. 2007
modified by Kean et al 2011. Briefly, 6 mL oral phase solution was added to the
formulated beverages (20 mL) described above. The reaction tube was vortexed briefly to
ensure mixing, blanketed with nitrogen, and incubated in a covered shaking water bath
(37°C, 85 opm, 10 min). Samples were then diluted to 30 mL with saline. The gastric
phase was initiated by addition of 2 mL porcine pepsin solution (20 mg/mL in 0.1 M HCl)
and adjustment of the pH to 3.0 ± 0.1 with 1.0 M HCl. After addition of saline for 40 mL
total solution, samples were blanketed with nitrogen and incubated in a covered shaking
water bath (37°C, 85 opm, 1 hr). The small intestinal phase was initiated by addition of
1.0 M NaHCO3 to raise the pH of gastric digesta (GD) to 6.5 ± 0.1. A cocktail of small
intestinal enzymes was added to the solution (2 mL, 30 mg/mL pancreatin, 15 mg/mL
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lipase in 0.1 M NaHCO3) as well as porcine bile salts (3 mL, 120 mg/mL bile extract in
0.1 M NaHCO3). The pH was then readjusted to 6.5 ± 0.1 with 1.0 M HCl and saline was
added for 50 mL total solution. Samples were then blanketed with nitrogen and incubated
in a covered shaking water bath (37°C, 85 opm, 2 hrs). After completion of the small
intestinal phase, samples were centrifuged (10,400 x g, 4°C, 1 hr).

Aliquots of

undigested beverage starting material (SM), GD, and centrifuged aqueous small intestinal
digesta (DG) were collected and acidified with 2% aqueous acetic acid (1:1) and stored
frozen at -80°C under a blanket of nitrogen until analysis by HPLC.

2.5

Flavan-3-ol Analysis by HPLC

Thawed aliquots of SM tea-protein beverages were extracted prior to analysis
following an enzyme-assisted extraction previously reported (Ferruzzi & Green 2006).
Aliquots from DG and extracted SM were diluted 1:1 with 2% acetic acid in dd water and
centrifuged at 14,000 x g for 5 minutes. Supernatants from both SM and DG were
collected and filtered through a 0.45 μm PTFE filter prior to analysis. 10 μL of
resolubilized sample was injected on an HP 1050 HPLC system equipped with a 12
channel CoulArray Multi-channel ECD Array system (ESA Inc). Separation was
achieved according to Peters et al. (2010) with minor modification. A Waters Xterra RPC18 column (3.9 mm id x 100 mm, 3.5 μM particle size) preceded by a guard column
packed with the same stationary phase was used to separate flavan-3-ols under gradient
conditions at a flow rate of 0.8 mL/min using a binary mobile phase of ddH2O,
acetonitrile, formic acid (91.9:8:0.1) in reservoir A and ddH2O, acetonitrile, methanol,
triflouroacetic acid (49.9:47:3:0.1) in reservoir B. Initial conditions of 90:10 A/B was
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followed by a linear gradient to 50:50 A/B (0-5 min), 10:90 A/B (5-7 min), 10:90 A/B (710 min), 90:10 A/B (10-12 min), and 90:10 A/B (12-15 min). 12-channel ECD was
performed with cell potentials at -100, 120, 180, 240, 300, 360, 420, 480, 540, 600, 660,
and 720 mV. Flavan-3-ols were quantified by summing responses obtained at 120, 180,
240, and 300 mV (channels 2-5).

2.6
2.6.1

Assessment of Protein-Flavan-3-ol Interactions Through in vitro Digestion
In vitro Digestion of S-CSN, β-LG, and α-LA for Assessment by SDS-PAGE

S-CSN, β-LG, and α-LA were digested in vitro for analysis by SDS-PAGE. To
obtain simple digests for clean SDS-PAGE analysis, digestions were carried out such that
only target protein, JK buffer, saline, pepsin, and pancreatin were present in final digests.
Digestions were completed in quadruplicate representing gastric times 0 and 1 hour, and
duodenal times 15, 30, 60, and 120 mins. Beverages (5.6 mL) containing protein (35.6
mg/mL acid casein, 1 mg/mL α-LA, or 3.5 mg/mL β-LG in JK) were mixed with 0.9%
saline for 8.4 mL total solution. The pH was adjusted to 3.0 ± 0.1 using 1.0 M HCl
followed by addition of pepsin solution (0.56 mL, 20 mg/mL) to simulate the gastric
phase. Gastric time 0 (G0) samples were frozen (-20°C), and freeze-dried for analysis.
Remaining samples were standardized to 11 mL, blanketed with nitrogen gas, parafilmed,
and incubated in a water bath (85 opm, 1 hr, 37°C). After incubation, gastric time 1 hour
(G1) samples were frozen (-20°C) and freeze-dried for analysis. Remaining samples were
adjusted to pH 6.5 ± 0.1 using 1.0 M NaHCO3. Pancreatin solution (0.56 mL, 30 mg/mL)
was added to simulate the duodenal phase, the pH was readjusted to 6.5, saline was added
for 14 mL total solution, and samples were covered with nitrogen, parafilmed, and
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incubated in a water bath (85 opm, 37°C) for 15, 30, 60, and 120 minutes. Duodenal
samples (D15, D30, D60, D120) were collected, frozen (-80°C), and freeze-dried for
analysis.

2.6.2

SDS-PAGE Analysis for Characterization of Milk Protein Digests

Raw material (α-LA, β-LG, S-CSN, pancreatin and pepsin) and freeze-dried digests
were characterized by SDS-PAGE using a Bio-Rad Mini-PROTEAN Tetra cell (BioRad
Laboratories, California, USA) using hand-casted gels (Gravel 2002). 10-20%
polyacrylamide gels were utilized for separation of proteins from raw materials and SCSN and β-LG digests. A 10% polyacrylamide gel was utilized for separation of protein
from α-LA digest. Freeze-dried samples from in vitro digestion of S-CSN, α-LA, and βLG were resolubilized in 10 mL, 280 μL, and 1 mL, respectively, of Tris-HCl (10 mM,
pH 7.4) for about 8 mg/mL protein total in sample. Samples were mixed 1:1 with BioRad 2x Laemmli buffer and boiled for 5 minutes before application onto gel. The gels
were stained using 2% Coommassie Blue solution and destained (Gravel 2002).
Molecular weights were estimated using a Bio-Rad broad range molecular weight marker
calibration kit (6,500 to 200,000 Da) for raw materials and S-CSN and β-LG digests, and
a Precision Plus Protein™ Kaleidoscope™ Standards calibration kit (10,00 to 250,000 Da)
for α-LA digest.
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2.6.3

Evaluation of Milk Protein-EGCG Interactions through Fluorescence
Spectroscopy

The in vitro digestion procedure used prior to analysis by SDS-PAGE (outlined in
section 2.6.1) was used with minor modification to digest S-CSN for fluorescence
analysis to determine extent of protein Trp fluorescence quenched by EGCG at various
points of digestion. S-CSN (0.023 g/L) was prepared in Tris-HCl (10 mM, pH 7.4) and
pH adjusted with NaOH to pH 6.3. Final digesta contained 0.0115 mg/mL S-CSN, 0.005
mg/mL pepsin, and 0.006 mg/mL pancreatin and had final pH of 3.0 or 6.5 for gastric and
duodenal digesta, respectively. According to preliminary results (See Appendix B),
aforementioned concentrations are appropriate to ensure S-CSN fluorescence is within
linear range of fluorometerand digestive enzyme Trp fluorescence interferes minimally
with S-CSN fluorescence. Gastric time zero (G0) samples were prepared by addition of 1
mL pepsin solution (0.07 mg/mL in 0.1 M HCl) and 1 mL pancreatin solution (0.084
mg/mL in 0.1 M NaHCO3) to 7 mL S-CSN solution. G0 samples were standardized to 14
mL with Tris-HCl pH 3.0, pH adjusted to 3.0, and frozen (-20°C). For remaining samples,
S-CSN (7 mL) was pH adjusted to 3.0 ± 0.1 by addition of 1.0 M HCl and made up to
8mL with saline. Subsequently, the gastric phase was initiated by addition of 1 mL pepsin
solution (0.07 mg/mL in 0.1M HCl) and samples were blanketed with nitrogen gas and
incubated in a shaking water bath (85 opm, 37°C, 1 hr).Pancreatin (1 mL, 0.084 mg/mL
in 0.1 M NaHCO3) was then added to gastric time one hour (G1) samples which were
made up to 14 mL with Tris-HCl pH 3.0, pH adjusted to 3.0, and frozen (-20°C). The
duodenal phase was initiated in remaining solutions by pH adjustment to 6.5 ± 0.1 and
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addition of 1mL pancreatin (0.084 mg/mL in 0.1 M NaHCO3). Samples were then
readjusted to pH 6.5 ± 0.1, made up to 12 mL with saline, blanketed with nitrogen gas
and incubated in a shaking water bath (85 opm, 37°C). Digestions were stopped at either
15, 30, 60, or 120 mins (D15, D30, D60, D120), made up to 14 mL with Tris-HCl pH 6.5,
pH adjusted to 6.5, and frozen (-20°C).
Additional experiments using S-CSN as a milk protein model were executed to
determine (1) extent of binding between EGCG and digestive enzymes and (2) S-CSNEGCG binding effects due to digestive pH. For both experiments, the digestion procedure
outlined in the previous paragraph was mimicked with minor changes (Table 8). Extent
of binding between EGCG and digestive enzymes was determined by incubating pepsin
and pancreatin at pH 3.0 and/or 6.5 without S-CSN prior to fluorometry. To determine SCSN-EGCG binding effects due to digestive pH, S-CSN was incubated at pH 3.0 and/or
6.5

without

presence

of

digestive

enzymes

prior

to

fluorometric

analysis.
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Table 8: Experimental conditions of digestions preceding fluorescence spectroscopy used
to determine (1) extent of binding between EGCG and digestive enzymes, (2) S-CSNEGCG binding effects due to digestive pH and (3) combined effect of protein digestion,
pH, and presence of enzymes in S-CSN digesta on fluorescence quenching of protein Trp
residues by EGCG.

Effect

S-CSN

Pepsin
and
Pancreatin

(1) EGCG-enzyme
(2) pH
(3) Full system

No
Yes
Yes

Yes
No
Yes

pH of
pH of
gastric
dudoenal
digesta
digesta
solution for solution for
fluorometry fluorometry
3.0
6.5
3.0
6.5
3.0
6.5

Fluorometric experiments were carried out on a Perkin-Elmer LS55 Spectrometer
(Woodbridge, ON, Canada). Method development was initiated following a method by
Kanakis et al. 2011.
An EGCG stock solution (12 µM in Tris-HCl (10 mM, pH 3.0 or 6.5)) was
prepared and kept on ice for analysis. EGCG was stable under these conditions with 98%
recovery over 6 h. S-CSN digested to various extents in vitro wasmixed 1:1 with EGCG
by inverting solution 10 times. EGCG concentration of each solution was about 6 µM,
and protein concentration of S-CSN was 0.0115 g/L. Pepsin and pancreatin were also
present from background digestion enzyme mixes at 0.005 and 0.006 mg/mL,
respectively, therefore, blanks containing milk protein and background digestive enzyme
mix mixed 1:1 with Tris-HCl (10 mM, pH 3.0 or 6.5) replacing EGCG were prepared.
Fluorescence spectra were obtained using λexc=280nm and λemi from 290-500nm.
Intensity at 350 nm (Trp) was recorded.
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Percentage fluorescence quenched was calculated using the following formula:

%Fq=[(F0-F)/F0]100
Where: F0= initial fluorescence intensity (intensity of blank)
F= fluorescence intensity in presence of quenching agent

Preliminary tests showed that EGCG mixed 1:1 with Tris-HCl (buffer) fluoresced
less than just Tris-HCl (Table C.1). In addition, it appeared EGCG quenched digestive
enzyme fluorescence. Due to its low impact on fluorescence and ability to quench some
enzyme fluorescence, EGCG fluorescence was not corrected for in calculations for
percent quenching of Trp residues by EGCG.

2.7

Data Analysis

Results calculated from LC-ECD data include both relative and absolute
bioaccessibilities of EGC, EC, EGCG, and ECG from each beverage. Bioaccessibility is
a measure of the digestive release and stability of a compound in the gut and is required
for the compound’s subsequent absorption. Relative bioaccessibility is defined as the
percent of flavan-3-ol recovered in final digesta relative to that in starting material.
Absolute bioaccessibility is the amount of flavan-3-ol available for absorption defined as
the relative bioaccessibility multiplied by grams of starting material and provides
information on impact of changes in digestive recoveries of each flavan-3-ol relative to
their abundance in GT. Percentage fluorescence quenched (%Fq) is the ratio of amount of
protein fluorescence lost due to addition of quencher (EGCG) compared to that of
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original protein fluorescence. Increased %Fq suggests increased quencher binding to Trp
residues. SDS-PAGE was used to separate peptides resulting from digestion of individual
proteins. Protein bands were compared to molecular weight ladder (6.5-200 kDa for SCSN and β-LG digests, 10-250 kDa for α-LA digests). Fading of bands and appearance
of lower molecular weight bands with increasing extent of digestion suggest degradation
of protein or peptide to smaller peptides. In vitro digestion and fluorometry data represent
mean +/- standard error of the mean of four individual samples. Analysis by one-way
ANOVA was performed using SAS 9.3 (SAS Institute, Cary, NC) for each variable and
control. Significant differences between treatments were evaluated by a Bonferroni
method (α< 0.05).
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CHAPTER 3. RESULTS

Consequence of milk addition on bioaccessibility and bioavailability of green tea
flavan-3-ols has been previously investigated using both in vivo and in vitro models.
Although results are conflicting between botanical matrices and approaches, there
appears to be consensus that there is potential for milk protein interaction to alter
bioaccessibility of tea flavan-3-ols in the gastrointestinal (GI) tract (Xie et al. 2012;
Green et al. 2007; van der Burg-Koorevaar et al. 2011) (Section 1.6.2.3, Table 5).
However, extent of this effect and putative involvement of individual milk proteins in
such interactions remain unclear. Additionally, many previous studies did not addresss
the role of milk minerals to modulate flavan-3-ol digestive stability or capacity for
protein binding. The purpose of this study was therefore to investigate extent to which
tea derived polyphenols (the flavan-3-ols) interact with specific milk proteins (α-LA, βLG, S-CSN), at relevant beverage concentrations and to determine the impact of these
interactions on digestive stability and bioaccessibility of green tea flavan-3-ols in an in
vitro three-stage gastrointestinal model.
There was no significant difference (p>0.05) in flavan-3-ol bioaccessibility between
green tea beverages formulated with 10, 20, and 40% of test material (Figures A.1, A.2,
A.3, and A.4 in Appendix). Therefore, results and discussion will be based on relative
and absolute bioaccessibility of green tea beverages formulated with 40% test material.
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As mentioned above, absolute bioaccessibility will be discussed to provide
information on the impact of changes in digestive recoveries of each flavan-3-ol relative
to their abundance in GT.

3.1

Starting Flavan-3-ol Profile of Green Tea Extract Beverages

Starting levels (SM) of total flavan-3-ols ranged from 42.16 to 57.52
μmol/digestion reaction (50 mL of model tea beverage) (Table 9). Beverages formulated
with NFDM had significantly lower (p<0.05) total flavan-3-ol level compared to
beverages formulated with JK control and α-LA, β-LG, and S-CSN solubilized in JK:
42.16±0.36 μmol of total flavan-3-ols per reaction compared to 52.18±0.20, 52.21±0.68,
49.05±0.77, and 57.52±1.90 μmol of total flavan-3-ols per reaction respectively. In
addition, SM level of total flavan-3-ols in beverages formulated with S-CSN in buffer (SCSN/JK) was significantly higher (p<0.05) compared to S-CSN in dd water (SCSN/water) and dd water controls with 57.52±1.90 compared to 48.56±0.61 and
46.33±2.19 μmol/digestion reaction respectively. No further differences in SM total
flavan-3-ols levels were observed.
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Table 9: Total flavan-3-ols in undigested model beverages (starting material-SM) and
digested model beverages (digesta-DG).Presence of different letters in same column
indicates significantly lower flavan-3-ol content between formulations.
Treatment

Total Flavan-3-ols in
SM (μmol/digestion
reaction)

Total Flavan-3-ols in
DG (μmol/digestion
reaction)

NFDM

42.16

± 0.36a,b

15.32

± 0.38 a

JK Control

52.18

± 0.20 a,c

16.86

± 0.66b

α-LA

52.21

± 0.68 a

13.90

± 0.74 a

β-LG

49.05

± 0.77 a

14.48

± 0.28 a

S-CSN in JK

57.52

± 1.90b

5.91

± 0.45b

dd Water Control

48.56

± 0.61 a,c

8.64

± 0.50b

S-CSN in Water

46.33

± 2.19c

5.42

± 0.26 a
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Table 10: Bioaccessibility (% and μg/g) of (a) EGC, (b) EC, (c) EGCG, and (d) ECG
from green tea beverages formulated with non-fat dry milk, buffer, water; α-LA, β-LG
and S-CSN/buffer; and S-CSN/water. Presence of different letters in same column
indicates significantly lower flavan-3-ol content between formulations.

Treatment

(a)

Non-Fat Dry Milk
JK Control
α-LA
β-LG
S-CSN/JK
Water Control
S-CSN/Water
Treatment

(b)

Non-Fat Dry Milk
JK Control
α-LA
β-LG
S-CSN/JK
Water Control
S-CSN/Water
Treatment

(c)

Non-Fat Dry Milk
JK Control
α-LA
β-LG
S-CSN/JK
Water Control
S-CSN/Water
Treatment

(d)

Non-Fat Dry Milk
JK Control
α-LA
β-LG
S-CSN/JK
Water Control
S-CSN/Water

Relative
µmol/digestion µmol/digestion
Bioaccessibility
reaction (SM) reaction (DG)
(%)
13.54 ± 0.09a
9.72 ± 0.25a
71.9 ± 1.4e
15.92 ± 0.08a
7.90 ± 0.64a
49.9 ± 4.7a
a
a
15.71 ± 0.26
7.12 ± 0.47
45.5 ± 2.8a,b
15.49 ± 0.38a
8.44 ± 0.25a
54.7 ± 0.3a,e
a
b,c
15.67 ± 0.76
1.40 ± 0.42
9.1 ± 2.4c
a
b
15.01 ± 0.23
4.08 ± 0.49
30.2 ± 0.9b,c
11.35 ± 1.55b
0.86 ± 0.24c
6.8 ± 1.0d
Relative
µmol/digestion µmol/digestion
Bioaccessibility
reaction (SM) reaction (DG)
(%)
c
b
3.70 ± 0.03
2.53 ± 0.09
68.7 ± 2.9c
a,b
a
4.53 ± 0.02
3.73 ± 0.06
82.6 ± 1.4a
4.21 ± 0.21a
3.34 ± 0.15c
79.7 ± 2.0a
a,b
b,c
4.39 ± 0.11
2.73 ± 0.08
62.8 ± 2.9b,c
4.76 ± 0.04b
2.74 ± 0.01b,c 58.1 ± 0.6b
a,c
4.15 ± 0.07
2.55 ± 0.03b 61.3 ± 1.1b,c
a,b
4.46 ± 0.12
3.00 ± 0.07c
67.9 ± 0.4b,c
Relative
µmol/digestion µmol/digestion
Bioaccessibility
reaction (SM) reaction (DG)
(%)
20.33 ± 0.34c
2.62 ± 0.27c
13.1 ± 1.2c
26.42 ± 0.17a
4.41 ± 0.13a
16.9 ± 0.5a
a,b
c
26.64 ± 0.57
2.89 ± 0.54
10.9 ± 1.8b,c
24.07 ± 0.65a,c
2.81 ± 0.09c
11.9 ± 0.6c
b
b,c
31.00 ± 1.69
1.39 ± 0.16
4.7 ± 0.6d
24.13 ± 0.55a,c
1.63 ± 0.08b,c
7.1 ± 0.2b,d
a
b
24.78 ± 1.52
1.14 ± 0.05
4.9 ± 0.1d
Relative
µmol/digestion µmol/digestion
Bioaccessibility
reaction (SM) reaction (DG)
(%)
c
b
4.59 ± 0.08
0.46 ± 0.05
10.9 ± 1.1b
a,b,c
a
5.30 ± 0.05
0.81 ± 0.02
16.1 ± 0.4a
5.64 ± 0.14a,c
0.55 ± 0.08b
10.4 ± 1.1b,c
a,b
b
5.10 ± 0.14
0.50 ± 0.02
10.7 ± 0.6b
6.09 ± 0.39b
0.16 ± 0.02b
7.1 ± 0.6c
a,b,c
b
5.27 ± 0.12
0.39 ± 0.01
8.1 ± 0.2b,c
5.75 ± 0.27a,b
0.42 ± 0.00b
8.2 ± 0.4b,c

Absolute
Bioaccessibility
(µmol/g)
141.6 ± 2.7c
98.3 ± 9.2a
89.6 ± 5.6a
107.6 ± 0.6a,c
17.8 ± 4.7b
59.4 ± 1.8b
13.5 ± 2.0b
Absolute
Bioaccessibility
(µmol/g)
25.7 ± 5.7b
30.9 ± 0.5a
29.8 ± 3.9a
23.5 ± 5.6b
21.7 ± 1.2b
22.9 ± 2.3b,c
25.4 ± 0.8c
Absolute
Bioaccessibility
(µmol/g)
31.4 ± 2.4a,b
40.5 ± 1.2a
26.2 ± 3.5b
28.6 ± 1.1b
11.3 ± 1.2c
16.9 ± 0.5b
11.7 ± 0.2b
Absolute
Bioaccessibility
(µmol/g)
4.4 ± 2.1b
6.5 ± 0.2a
4.2 ± 2.2b
4.3 ± 1.2b
2.9 ± 1.2b
3.3 ± 0.4b,c
3.3 ± 0.7b,c
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Individual tea flavan-3-ols in SM including EGC, EC, EGCG, and ECG ranged
from 3.7 to 31.0 μmol/digestion reaction (Figures 6 and 8, Table 10). No significant
difference in individual SM flavan-3-ol level was found between dd water and buffer
formulations.

For individual flavan-3-ols in NFDM beverages, EC (3.70±0.03

μmol/digestion reaction) was significantly lower (p<0.05) compared to all treatments
except dd water; EGCG (20.33±0.34 μmol/digestion reaction) was lower compared to JK
buffer (p<0.05) and beverages formulated with S-CSN and α-LA (p<0.05); and ECG
(4.59±0.08 μmol/digestion reaction) was lower compared to beverages formulated with
S-CSN and β-LG (p<0.05). In addition, SM levels of EGCG in model beverages
formulated with S-CSN/JK (31.00±1.69 μmol/digestion reaction) were significantly
higher (p<0.05) compared to all treatments except α-LA. Levels of individual flavan-3ols in beverages formulated with JK buffer, α-LA, and β-LG were not significantly
different from each other.
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Figure 6: Levels of (a) EGC, (b) EC, (c) EGCG, and (d) ECG in starting material and
aqueous digesta of green tea beverages formulated with sodium caseinate in JK buffer or
dd water and dd water and JK buffer controls. Presence of different letters within raw
material or aqueous digesta data indicates significantly different flavan-3-ol content
between formulations.
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3.2

Green Tea Flavan-3-ol Bioaccessibility in Milk Mineral Buffer (JK)

Initial flavan-3-ol levels in model beverage systems (SM) following simulated oral,
gastric and small intestinal digestion were assessed (Figures 6 and 8, Table 10) to
determine the impact of milk minerals on flavan-3-ol bioaccessibility. Initial assessment
focused on the impact of JK buffer relative to dd water on tea flavan-3-ol in vitro
digestive stability/bioaccessibility. It appears that presence of milk minerals from JK
buffer significantly increased digestive stability of flavan-3-ols relative to dd water
formulation (p<0.05).
Total flavan-3-ols levels in JK buffer control final digesta (DG) (16.86±0.66
μmol/digestion reaction) was significantly higher (p<0.05) than in dd water control DG
(8.64±0.50 μmol/digestion reaction) (Figure 6, Table 9). Beverages formulated with JK
buffer had significantly higher (p<0.05) DG levels of EGC, EC, EGCG, and ECG
compared to dd water control beverage with 7.90±0.64, 3.73±0.06, 4.41±0.13 and
0.81±0.02 μmol/digestion reaction compared to 4.08±0.49, 4.15±0.07, 1.63±0.08, and
0.39±0.01 μmol/digestion reaction respectively (Table 10). These levels represent a
significant increase (p<0.05) in bioaccessibility of all tea flavan-3-ols in beverages
formulated with JK buffer compared to those formulated with dd water from 30.2±0.9,
61.3±1.1, 7.1±0.2, and 8.1±0.2% to 49.9±4.7, 82.6±1.4, 16.9±0.5, and 16.1±0.4% for
EGC, EC, EGCG, and ECG, respectively (Figure 7, Table 10). These values represent
increases in absolute bioaccessibilities from 59.4±1.8, 22.9±2.3, 16.9±0.5, and 3.3±0.4
μmol/g for dd water controls to 98.3±9.2, 30.9±0.5, 40.5±1.2, and 6.5±0.2 μmol/g for
buffer controls, respectively.
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Figure 7: (a) Relative (%) and (b) absolute (μg/g) bioaccesibility of flavan-3-ols from
green tea beverages formulated with sodium caseinate in dd water or buffer, and dd water
and buffer controls.Presence of different letters indicates significantly different flavan-3ol recovery between formulations.

3.3

Green Tea Flavan-3-ol Bioaccessibility in Non-Fat Dry Milk (NFDM)
Formulations

Green tea beverages were formulated with NFDM to determine effects of the full
milk matrix on flavan-3-ol digestive stability and bioaccessibility. Bioaccessibility of
flavan-3-ols from beverages formulated with NFDM was compared with dd water control
to parallel past studies concerning bioaccessibility of tea flavan-3-ols from beverages
formulated with milk/creamer compared to dd water controls. NFDM is obtained by
removal of water only (21CFR131.125) and thus reconstituted NFDM used in this study
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contained both milk proteins and milk minerals in the same relative proportions found in
milk. Therefore, NFDM formulations were also compared to JK buffer control to focus
on impacts of milk protein on flavan-3-ol bioaccessibility while minimizing observations
of changes in bioaccessibililty due to presence of milk mineral.
Total flavan-3-ol levels in NFDM DG (15.32±0.38 μmol/digestion reaction) were
not significantly different (p>0.05) than JK buffer control DG (16.86±0.66
μmol/digestion reaction), but were significantly higher than dd water control (8.64±0.50
μmol/digestion reaction) (Table 9). Interestingly, the overall trend for impact on
individual flavan-3-ol bioaccessibility by formulation of green tea extract beverages with
NFDM was different depending on whether milk mineral buffer was present (Figure 7,
Table 10). Flavan-3-ol bioaccessibility generally increased with addition of NFDM
compared to dd water control, but decreased compared to buffer control. Levels of EGC
and EGCG in NFDM based beverage DG were 9.72±0.25 and 2.62±0.27 μmol/digestion
reaction (Figure 6, Table 10) translating to significantly improved (p<0.05)
bioaccessibilities of EGC and EGCG from NFDM formulations compared to dd water
control from 30.2±0.9 and 7.1±0.2% (59.4±1.8 μmol/g and 16.9±0.5 μmol/g) to 71.9±1.4
and 13.1±1.2% (141.6±2.7 and 31.4±2.4 μmol/g), respectively (Figure 7, Table 10). EC
and ECG were present in NFDM DG at 2.5±0.1 and 0.5±0.1 μmol/digestion reaction
(Figure 6). Bioaccessibilities of EC and ECG from NFDM formulations were 68.7±2.9%
(25.7±5.7 μmol/g) and 10.9±1.1% (4.4±2.1 μmol/g), respectively and were not
significantly different (p>0.05) compared to dd water based tea beverage control (Figure
7, Table 10).
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Compared to buffer control, bioaccessibility of EGC was significantly (p<0.05)
higher, increasing from 47.5±3.0% to 71.9±1.4% (98.3±9.2 μmol/g to 141.6 μmol/g) by
addition of NFDM (Figure 7, Table 10). However relative bioaccessibility of EC, EGCG,
and ECG were significantly (p<0.05) decreased to 68.7±2.9, 13.1±1.2, and 10.9±1.1%
from 82.6±1.4, 16.9±0.5 and 16.1±0.4%, respectively, compared to JK buffer controls by
addition of NFDM (Figure 7, Table 9). In terms of absolute bioaccessibility, EC, EGCG,
and ECG decreased to 25.7±5.7, 31.4±2.4, and 4.4±2.1 μmol/g from 30.9±0.5, 40.5±1.2,
and 6.51±0.2 μmol/g, respectively, compared to JK buffer controls by addition of NFDM.
Although there was no significant difference (p>0.05) in flavan-3-ol
bioaccessibility from green tea beverages formulated with 10, 20, and 40% of test
material (p<0.05) (See Appendix Figure A.1), it appears that relative and absolute
bioaccessibility of EGC from green tea beverages formulated with 40% NFDM
formulations (71.9±1.4% and 141.6±2.7 μg/g) are higher than formulations containing 10%
of the test material (57.5±1.4% and 113.2±2.7 μg/g).

3.4

Green Tea Flavan-3-ol Bioaccessbility in Sodium Caseinate (S-CSN), Milk
Mineral, and Water Formulations

Effects of S-CSN formulated in dd water and S-CSN formulated in JK buffer on tea
flavan-3-ols were compared to dd water and JK buffer controls, respectively. In addition,
differences between S-CSN treatments were investigated to better define the role of
protein in presence and absence of milk minerals. S-CSN was chosen as a model to
investigate impact of milk serum on interactions between milk protein and flavan-3-ols
because casein is the milk protein most reported to interact with flavan-3-ols based on
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examination of literature (Arts et al. 2002; Lorenz et al. 2007; Shpigelman et al. 2012;
Hasni et al. 2011; Kanakis et al. 2011; von Staszewski et al. 2012; Bohin et al. 2012).
Additionally, S-CSN in JK (S-CSN/JK) formulation was compared to NFDM to
determine extent to which S-CSN may be responsible for observed NFDM effects.
Interestingly, flavan-3-ol bioaccessibility from beverages formulated with S-CSN was
significantly (p<0.05) lower than beverages formulated with NFDM. In regards to impact
of milk mineral buffer on S-CSN-flavan-3-ol interactions, there appears to be no overall
effect.
Total flavan-3-ols level in S-CSN/JK DG (5.91±0.45 μmol/digestion reaction) was
significantly lower (p<0.05) than JK control (16.86±0.66 μmol/digestion reaction) (Table
9). S-CSN/JK had significantly (p<0.05) decreased DG levels of each individual flavan3-ol compared to buffer control (Figure 6, Table 10). Specifically, levels of EGC, EC,
EGCG, and ECG in S-CSN/JK DG were 1.40±0.42, 2.74±0.01, 1.39±0.16, 0.16±0.02
μmol/digestion reaction. Accordingly, relative bioaccessibilities of EGC, EC, EGCG, and
ECG from beverages formulated with S-CSN/JK were significantly lower (p<0.05)
compared to JK control decreasing from 49.9±4.7, 82.6±1.4, 16.9±0.5, and 16.1±0.4% to
9.1±2.4, 58.1±0.6, 4.7±0.6, and 7.1±0.6% (Figure 7, Table 10). In absolute terms, SCSN/JK significantly (p<0.05) decreased bioaccessibility of all flavan-3-ols compared to
JK control from 98.3±9.2, 30.9±0.5, 40.5±1.2, and 6.5±0.2 μmol/g to 17.8±4.7, 21.7±1.2,
11.3±1.2, and 2.9±1.2 μmol/g respectively for EGC, EC, EGCG and ECG.
Total flavan-3-ols level in aqueous S-CSN (S-CSN/water) DG (5.42±0.26
μmol/digestion reaction) was not significantly different (p>0.05) than dd water control
(8.64±0.50 μmol/digestion reaction) (Table 9). However, beverages formulated with S-
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CSN/water had significantly lower and higher (p<0.05) DG levels of EGC and EC,
respectively, compared to dd water control beverages with 0.86±0.24 and 3.00±0.07
relativeto 4.08±0.49 and 2.55±0.03 μmol/digestion reaction EGC and EC, respectively
(Figure 6, Table 10). There was no significant difference (p>0.05) in DG levels of EGCG
and ECG from S-CSN/water formulations (1.14±0.05 and 0.42±0.00 μmol/digestion
reaction, respectively) compared to dd water control beverages (1.63±0.08 and 0.39±0.01
μmol/digestion reaction, respectively). In terms of bioaccessibility, S-CSN/water
significantly decreased (p<0.05) bioaccessibility of only EGC compared to dd water
control from 30.2±0.9 to 6.8±1.0% (59.4±1.8 to 13.5±2.0 μmol/g), but did not
significantly (p>0.05) affect bioaccessibility of remaining flavan-3-ols compared to
control (Figure 7, Table 10).
Individual flavan-3-ol levels in S-CSN/JK DG were not significantly different
(p>0.05) from levels in S-CSN/water DG (Figure 6, Table 10). Similarly, relative and
absolute bioaccessibilities of each flavan-3-ol from S-CSN/JK compared to S-CSN/water
formulations were not significantly different (p<0.05) (Figure 7, Table 10). Compared to
NFDM,

both

S-CSN/JK

and

S-CSN/water

formulations

decreased

relative

bioaccessibility of EGC and EGCG following in vitro digestion to 9.1±2.4 and 4.7±0.6%
(17.8±4.7 and 11.3±1.2 μmol/g) from beverages formulated with S-CSN/JK, and to
6.8±1.0 and 4.9±0.1% (13.5±2.0 and 11.7±0.1 μmol/g) from beverages formulated with
S-CSN/water. In addition, both EC and ECG bioaccessibility were significantly
decreased (p<0.05) by formulation withS-CSN/JK buffer compared to formulation with
NFDM from 68.7±2.9 and 10.9±1.1% (25.7±5.7 and 4.4±2.1 μmol/g) to 58.1±0.6 and
7.1±0.6% (21.7±1.2 and 2.9±1.2 μmol/g) respectively (Figure 7, Table 10).
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Interestingly, although there was no significant dose dependent effect (p>0.05) on
bioaccessibility of each flavan-3-ol for any treatment tested, it appears that relative and
absolute bioaccessibility of EGC from green tea beverages formulated to 40% with SCSN (9.1±2.4% and 17.8±4.7 μg/g for S-CSN/JK buffer, 6.8±1.0% and 13.5±2.0 μg/g for
S-CSN/water) are lower than formulations formulated to 10% of the test material
(22.6±2.7% and 44.4±5.2 μg/g for S-CSN/JK buffer, 26.4±3.1% and 52.1±6.1 μg/g for SCSN/water) (Figure A.2).

3.5

Green Tea Flavan-3-ol Bioaccessibility in Beverages Formulated with Individual
Whey Proteins and Milk Minerals
The impact of individual whey proteins on flavan-3-ol bioaccessibility was

investigated. Both α-LA and β-LG were formulated in JK buffer at levels that represent
those found in fat-free milk to better compare effects of each protein relative to JK buffer
control, NFDM and S-CSN/JK formulations.
Total flavan-3-ols level in α-LA in buffer DG (13.90±0.74 μmol/digestion reaction),
β-LG in buffer DG (14.48±0.28 μmol/digestion reaction) and buffer control DG
(16.86±0.66 μmol/digestion reaction) were not significantly different (p>0.05) than dd
water control (8.64±0.50 μmol/digestion reaction) (Table 9). With regards to individual
flavan-3-ols, absolute levels of EGC in DG of beverages formulated with α-LA and β-LG
(7.12±0.47 and 8.44±0.25 μmol/digestion reaction, respectively) were not significantly
different (p>0.05) compared to buffer without protein added (7.90±0.64 μmol/digestion
reaction) (Figure 8, Table 10). In terms of bioaccessibility, whey proteins had no
significant affect (p>0.05) on EGC bioaccessibility compared to buffer control (Figure 9,
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Table 10). Relative bioaccessibilities of EGC from α-LA and β-LG were 45.5±2.8 and
54.7±0.3%, respectively, and absolute bioaccessibilities were 89.6±5.6 and 107.6±0.6
μmol/g, respectively (Figure 9, Table 10).
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Figure 8: Levels of (a) EGC, (b) EC, (c) EGCG, and (d) ECG in starting material and
aqueous digesta of green tea beverages formulated with whey proteins or sodium
caseinate in buffer and buffer control. Presence of different letters within raw material
and aqueous digesta data indicates significantly different flavan-3-ol content between
formulations.
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Figure 7: Relative bioaccessibility (%) of flavan-3-ols from green tea beverages
formulated with whey proteins or sodium caseinate in buffer and buffer controls.
Presence of different letters indicates significantly different flavan-3-ol recovery between
formulations.

Beverages formulated with individual whey proteins had significantly decreased
DG levels of EC, EGCG and ECG compared to JK control: their respective levels in αLA DG were 3.34±0.15, 2.89±0.54 and 0.55±0.8 μmol/digestion reaction; and in β-LG
DG were 2.73±0.08, 2.81±0.09, and 0.50±0.02 μmol/digestion reaction (Figure 8, Table
10). Bioaccessibilities of EGCG and ECG were significantly (p<0.05) decreased by α-LA
compared to buffer control to 10.9±1.8 and 10.4±1.1% (26.2±3.5 and 4.2±2.2 μmol/g),
respectively (Figure 9, Table 10). However, bioaccessibility of EC from α-LA
formulation (79.7±2.0%, 29.8±3.9 μmol/g) was not significantly different (p>0.05)
compared to buffer control. β-LG significantly decreased (p<0.05) bioaccessibilities of
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EC, EGCG, and ECG compared to buffer control to 62.8±2.9, 11.9±0.6, and 10.7±0.6%,
respectively (23.5±5.6, 28.6±1.1, and 4.3±1.2 μmol/g, respectively).
Flavan-3-ol relative bioaccessibility from whey protein formulated beverages were
compared to NFDM formulations to determine extent to which they may be responsible
for effects from a more complex NFDM system (Figure 9, Table 10). Compared to
NFDM, α-LA significantly (p<0.05) decreased relative bioaccessibility of EGC to
45.5±2.8% (89.6±5.6 μmol/g) and significantly increased (p<0.05) bioaccessibility EC to
79.7±2.0% (29.8±3.9 μmol/g), but did not significantly (p>0.05) affect bioaccessibility of
EGCG or ECG. No significant (p<0.05) differences in bioaccessibility of individual
flavan-3-ols were found between β-LG and NFDM formulations.
Bioaccessibility of flavan-3-ols from whey protein in JK buffer formulations was
also compared to bioaccessibility of those from S-CSN in buffer formulations (Figure 9,
Table

10).

Whey protein

formulations

had

significantly increased

(p<0.05)

bioaccessibilities of gallated flavan-3-ols compared to S-CSN in buffer formulations. In
addition, α-LA and β-LG formulations had significantly increased EC and ECG
bioaccesibility compared to S-CSN in buffer formulations.

3.6

Protein Digestibility through Simulated GI Model

SDS-PAGE analysis was utilized to characterize extent of protein digestion through
the in vitro digestion model utilized for the bioaccessibility study (Figure 10). According
to preliminary results, the most prominent bands for each raw material used in this
investigation correspond to protein with the following molecular weights: <14.4 kDa for
α-LA; 14.4 kDa for β-LG; and 25 and 30 kDa for S-CSN. Prominent bands for
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background enzymes correspond to protein with molecular weights ranging from 25 to 70
kDa for pancreatin, and 66 kDa for pepsin (See Appendix Figure B.1). For all protein
digestas, it appears that after 1 hour of gastric digestion bands resulting from separation
of undigested digested protein are present, but at lower concentrations. Furthermore, it
appears that protein had been digested to form lower molecular weight peptides.
Specifically, it appears proteins present in S-CSN G0 (undigested) range from 14-35 kDa,
with most of them between two large bands: one around 25 and one around 30 kDa. All
proteins above 14 kDa disappeared after one hour of digestion (S-CSN G1), and thick,
faint protein bands appeared below 14 kDa. β-LG G0 had one prominent protein band
just above 14 kDa, which corresponds to β-LG monomer (molecular weight 18.4 kDa) in
agreement with other studies (J. Mouécoucou et al. 2004; Mandalari et al. 2009; Otte et al.
1997). This band is present in β-LG G1, but is less prominent. These results indicate
some level of protein digestion during gastric phase consistent with exposure to pepsin.
Changes in protein profile of α-LA, however, are harder to distinguish due to poor
resolution of low molecular weight proteins by the type of gel used in this study.
For all milk proteins, bands present following gastric digestion disappeared after just
15 minutes of small intestinal digestion. This indicates that proteins and large
polypeptides were rapidly digested to molecular weights less than 10 kDa from exposure
to pancreatin during small intestinal digestion (Figure 10).
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Figure 10: Protein profile of (a) S-CSN, (b) β-LG, and (c) α-LA digests. The following
are the lane designations for each gel: Lane 1 (and lane 9 in Figure 1.C): molecular
weight markers; lanes 2 and 3: peptic digests (0 and 1 hour incubation, respectively);
lanes 4-7: pancreatic digests (15, 30, 60, and 120 minutes incubation, respectively); lane
8: background enzymes (pepsin, pancreatin).
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3.7

Characterization of Milk Protein-EGCG Binding by Fluorescence Spectroscopy
Conditions of digestive environment and protein digestion may impact

interactions between flavan-3-ols and protein/peptides. As sodium caseinate is the most
abundant protein in milk, it was chosen as the model protein to investigate: (1) S-CSNEGCG binding interactions facilitated by digestive pH (gastric pH 3.0, duodenal pH 6.5)
(2) extent of binding between EGCG and digestive enzymes and (3) combined effect of
protein digestion, pH, and presence of enzymes in S-CSN digesta on fluorescence
quenching of protein Trp residues by EGCG (Table 11, Figure 12).
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Figure 12: Percent Trp fluorescence quenched of protein solutions by EGCG. S-CSN
solutions and EGCG (12μM) or Tris HCl were mixed 1:1 for analysis by fluorescence
spectroscopy. Each line represents one of three different procedures used to determine:
(
) extent of binding between EGCG and digestive enzymes, (
) S-CSN-EGCG
binding effects due to digestive pH (gastric pH 3.0, duodenal pH 6.5), and (
)
combined effect of protein digestion, pH, and presence of enzymes in S-CSN digesta on
fluorescence quenching of protein Trp residues by EGCG. The area of the graph before
the first vertical dotted line corresponds with untreated protein, followed by protein
incubated at gastric conditions, and protein incubated at duodenal conditions.
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Table 11: Percent Trp fluorescence quenched by EGCG of protein solutions. Protein
solutions and EGCG (12μM) or Tris HCl were mixed 1:1 for analysis by fluorescence
spectroscopy. Each line is one of four different procedures used to determine: (1) extent
of binding between EGCG and digestive enzymes (2) S-CSN-EGCG binding effects due
to digestive pH (gastric pH 3.0, duodenal pH 6.5) and (3) combined effect of protein
digestion, pH, and presence of enzymes in S-CSN digesta on fluorescence quenching of
protein Trp residues by EGCG. Different letters between digests within a treatment
denotes significant difference (p<0.05).
Treatment

(1) Enzymes,
pH 3 and 6.5

Incubation
G0
G1
D15
D30
D60
D120

(2) S-CSN,
no enzymes,
pH 3 and 6.5

G0
G1
D15
D30
D60
D120

(3) S-CSN,
enzymes,
pH 3 and 6.5

G0
G1
D15
D30
D60
D120

Fluorescence
Quenched (%)
19.2 ± 1.1a,b
23.0 ± 1.4a
14.8 ± 1.6b,c
13.6 ± 0.4c
16.0 ± 0.8b,c
17.0 ± 0.6,c
29.8 ± 1.6a
32.6 ± 0.5a,c
42.6 ± 3.9b
41.1 ± 1.4b
39.5 ± 1.7b,c
40.8 ± 1.5b,c
13.1 ± 2.4a
16.7 ± 0.5a
15.2 ± 1.6a
13.9 ± 0.9a
13.9 ± 1.4a
14.5 ± 2.2a

%Fq of S-CSN incubated at gastric pH and 37°C for 0 or 1 hr (GpH0, GpH1) was
29.8±1.6 and 32.6±0.5% (Table 11, Figure 12). %Fq of S-CSN incubated at duodenal pH
and 37°C for 15 min to 2 hr (DpH15, DpH30, DpH60, DpH120) was higher in
comparison ranging from 39.5±1.7 to 42.6±3.9%. S-CSN GpH0 had significantly lower
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(p<0.05) %Fq compared to all S-CSN samples incubated at duodenal pH: %Fq was
29.8±1.6% for GpH0 compared to 42.6±3.9, 41.1±1.4, 39.5±1.7, and 40.8±1.5% for SCSN DpH15, DpH30, DpH60, and DpH120. However, S-CSN GpH1 %Fq (32.6±0.5)
was significantly lower (p<0.05) compared DpH15 and DpH30, but not DpH60 and
DpH120. No significant differences (p<0.05) were found within gastric or duodenal
samples.
%Fq of enzymes incubated at gastric pH for 0 or 1 hr at 37°C (EG0, EG1) was
19.2±1.1 and 23.0±1.4% (Table 11, Figure 12). %Fq of enzymes incubated at duodenal
pH for 15 to 120 min at 37°C (ED15, ED30, ED60, ED120) was lower, ranging from
13.6±0.4 to 17.0±0.6%. EG1 %Fq was significantly higher (p<0.05) compared to all
enzyme samples incubated at duodenal pH: %Fq was 23.0±1.4% for EG1 compared to
14.8±1.6, 13.6±0.4, 16.0±0.8, and 17.0±0.6% for ED15, ED30, ED60, and ED120.
However, EG0 %Fq (19.2±1.1%) was significantly higher (p<0.05) compared to only
ED30. No significant (p<0.05) differences were found within gastric or duodenal samples.
%Fq of each digesta resulting from digestion of S-CSN by pepsin for 0 to 1 hour
at 37°C and pH 3.0±0.1 (FG0, FG1) and by pancreatin for 15 to 120 minutes at 37°C and
pH 6.5±0.1 (FD15, FD30, FD60, FD120) ranged from 13.1±2.4 to 16.7±0.5% (Table 11,
Figure 12). There were no significant differences (p<0.05) in %Fq between samples. FG0,
FG1, FD15, FD30, FD60, and FD120 %Fq were 13.1±2.4, 16.7±0.5, 15.2±1.6, 13.9±0.9,
13.9±1.4, and 14.5±2.2%.
%Fq from S-CSN samples incubated without enzyme (GpH0 to DpH120) were
significantly higher (p<0.05) compared to all enzyme samples incubated without protein
(EG0 to ED120) and all S-CSN digesta pH adjusted to gastric or duodenal pH before
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fluorometric analysis (FG0 to FD120) (See Appendix Table C.4). However, %Fq EG0
and EG1 was higher compared to only FG0 and FG1, but the difference was not
significant (p>0.05).
.
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CHAPTER 4. DISCUSSION

Prior studies have investigated binding interactions between monomeric flavan-3-ols
and proteins derived from foods and from the body (ie. digestive enzymes). With regards
to milk proteins, evidence suggests that α- and β-CSN, α-LA, and β-LG all have capacity
to interact with EGCG, as well as other flavan-3-ols, binding non-specifically with
various affinities (Almajano et al. 2007; Hasni et al. 2011; Kanakis et al. 2011; von
Staszewski et al. 2012; Bohin et al. 2012; Jöbstl et al. 2006; Tantoush et al. 2012; Prigent
et al. 2009). Non-specific binding of milk proteins with flavan-3-ols occurs primarily
through hydrophobic interactions (driven by London dispersion interactions) and
hydrogen bonding interactions and, to a lesser extent, electrostatic interactions.
Interactions tend to increase with polyphenol molecular weight, hydrophobicity,
galloylation, hydroxyl groups, and decrease with methylation, methoxylation,
glycosylation, and hydrogenation of the C2=C3 double bond (Soares et al. 2007; de
Freitas et al. 2001; Baxter et al. 1997; Xiao et al. 2011; Xu & Chen 2011; Papadopoulou
et al. 2005). Protein characteristics that promote interactions with polyphenols include
presence of proline, histidine, arginine, phenylalanine and hydrophobic pockets and
residues (Yan et al. 1995; Naurato et al. 1999; Charlton et al 2002; Baxter et al. 1997;
Charlton et al. 2001; Soares et al. 2007; Papadopoulou et al. 2005). Types and strengths
of interactions between specific flavan-3-ols and milk proteins have been outlined in
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Table 2 (See Section 1.6.2). Implications of such interactions in food extend to the GI
after consumption as non-specific binding may alter availability of flavan-3-ols for
reactions and absorption. While limiting accessibility for reactions, binding may serve to
stabilize polyphenol with respect to potential oxidative degradation, and strong binding
may serve to make these phenolics less available for absorption (bioaccessibility).
Therefore understanding extent and implications of such interactions is needed in order to
optimize stability but also availability of polyphenols for delivery of health benefits.
The ability of protein to influence flavan-3-ol bioavailability remains controversial.
While minimal impact on bioavailability of flavan-3-ols has been observed in clinical
studies with black tea based systems (van het Hof et al. 1998; Kyle et al. 2007), in cocoa
products, presence of milk protein appears to have a negative effect on monomeric
flavan-3-ol bioavailability (Serafini et al. 2003; Neilson et al. 2009).

The influence of

protein on tea flavan-3-ol bioactivity however, has been observed. Milk had no effect on
plasma antioxidant activity following consumption of green or black tea by humans in
vivo (Leenan et al. 2000), however milk decreased vasorelaxation effects of black tea in
humans (Lorenz et al. 2007). While many studies attribute changes in bioactivity to
reduced bioavailability, this effect is unclear. Further, the impact of minerals derived
from milk on flavan-3-ol stability and bioavailability has not been truly explored.
Considering the important interplay between protein-minerals, minerals-flavan-3-ols and
flavan-3-ols-protein, additional insight is needed.

The purpose of this study was

therefore to determine effects of key milk proteins individually and in NFDM matrix as
well as milk minerals, in the form of JK buffer, on digestive stability and ultimate
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bioaccessibility of green tea flavan-3-ols. As a secondary objective extent to which nonspecific binding of flavan-3-ols to milk protein during digestion was assessed by
fluorometry.
Relative (%) and absolute (μg/g) bioaccessibility was calculated for green tea
beverages formulated with three different concentrations (10, 20, 40%) of each test
material. There was no significant (p>0.05) concentration effect for any treatment tested
(Figures A.1-A.4). Therefore, it is important to note that this discussion will be based
primarily on bioaccessibility of flavan-3-ols from green tea powdered extract formulated
into model beverages with 40% test material (protein or buffers).

4.1

Impact of Milk Minerals on Flavan-3-ol Bioaccessibility

Green tea powder was formulated with either JK buffer or dd water into model
beverage systems and subjected to in vitro digestion to determine the impact of milk
minerals on digestive stability of flavan-3-ols. Auto-oxidative degradation of flavan-3-ols
during gastrointestinal digestion has been previously reported (Yoshino et al. 1999; Zhu
et al. 2002; Green et al. 2007; Neilson et al. 2007; Ferruzzi et al. 2010). These reactions
are facilitated by the elevated pH of the small intestine and rely on reactivity of the
flavan-3-ol B-ring making EGC and EGCG more suceptable to oxidative loss by virtue of
their galloyl structure relative to the catechol structure of EC and ECG (Neilson et al.
2007). Degradation of flavan-3-ols in model beverages formulated with dd water was
consistent with those previously reported for tea (Green et al., 2007; Neilson et al., 2007;
Record & Lane, 2001).

Interestingly, bioaccessibilities of all flavan-3-ols were

significantly improved by addition of milk mineral rich JK buffer to beverage
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formulation (p<0.05) relative to dd water (Figure 7, Table 10). This effect waslikely due
to presence of divalent metal ions including calcium (Ca) and magnesium (Mg) at levels
of 35.9 mg/100mL (9 mM) and 7.8 mg/100mL (3.3 mM), respectively, in the JK buffer
system utilized in these studies. These minerals have been previously shown to interact
with polyphenols in various foods altering both mineral stability and bioaccessibility
(Vitali et al. 2008; Al-Numair 2009).
In terms of potential polyphenol interactions, several studies have reported
interactions between catechols, flavonoids and select metals (Namasivayam & Sumithra
2004; Turkel et al. 2004). Polyphenols are well known as metal chelators (Hagerman et al.
2003; Sugihara et al. 2001; Hider et al. 2001; Kumamoto et al. 2001). Results from IR
analysis (Yamada et al. 2007) suggest that calcium chelation occurs by either two
hydroxyl groups within catechols, commonly present on the B-ring of flavan-3-ols, or by
calcium bridging formations between multiple catechols. Flavonoids complexed in such a
manner with metal were reported to be less susceptible to oxidation compared to
uncomplexed flavanoids (Kostyuk et al. 2004). As previously stated, auto-oxidation is
believed to be the primary degradative pathway for flavan-3-ols in the gut lumen due, in
part, to the elevated pH of the intestinal compartment (Green et al. 2007; Nielson et al.
2007). In the case of the present study it is highly likely that milk minerals provide a
measure of stabilization through their ability to reduce oxidative reactivity of individual
tea flavan-3-ols, including highly susceptible EGC and EGCG. These control
experiments were thus critical in our ability to distinguish effects in more complicated
milk protein systems that also contain significant amounts of minerals that may compete
for interactions with flavan-3-ols and alter their stability and subsequent bioaccessibility.
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4.2

Impact of NFDM on Flavan-3-ol Bioaccessibility

In order to determine the impact of milk proteins on flavan-3-ol bioaccessibility
we first formulated green tea beverages with reconstituted NFDM (10-40%) generating
products similar to 10-40% single strength milk addition to tea. These model beverages
were compared to green tea beverages formulated with dd water to determine effects of
the entire milk matrix on flavan-3-ol digestive stability and to evaluate the relationship
with that reported by previous investigators (Green et al. 2007; van der Burg-Koorevaar
et al. 2011; Xie et al. 2012). Tables 4 and 5 outline beverage type and polyphenol and
milk protein content used for aforementioned in vivo and in vitro protein-polyphenol
interaction studies. Beverages formulated with NFDM were found to have significantly
higher (p<0.05) relative and absolute bioaccessibility of EGC and EGCG compared to
those formulated with dd water, however, no significant impacton bioaccessibility of EC
and ECG was observed (Figure 7, Table 10). Green et al. (2007) previously reported that
formulation of green tea beverages (49 mg/mL flavan-3-ols) with up to 50% milk
improved bioaccessibility of EGC and EC, with no impact to bioaccessibility of EGCG,
and decreasing bioaccessibility of ECG. However, addition of milk at 10 and 20%
increased bioaccessibility of EGC and was reported to have no effect on bioaccessibility
of remaining flavan-3-ols. In another study, formulation of milk to as low as 10% in
boiled green tea (75 mg/mL flavan-3-ols) decreased bioaccessibility of gallated flavan-3ols, and formulation of milk up to 25% had no effect on bioaccessibility of EGC and EC.
However, formulation of milk to 10% in ambient temperature green tea decreased
bioaccessibility of EC, and an increase of milk in formulation to 25% decreased
bioaccessibility of gallated flavan-3-ols. While our current findings are similar to those
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previously described, beverage preparation and temperature may be responsible for subtle
differences in reported interactions and impacts of these protein-flavan-3-ol interactions
(Xie et al. 2012). Further, inconsistencies in results between studies discussed here may
be due to differences in experimental design including: type of digestion (three-stage vs.
two-phase); level of digestive enzymes used;environmental conditions (pH of duodenal
phase); and formulation (amount and type of tea or milk).
Based on the general chemistry of proteins and flavan-3-ols present in GT-NFDM
beverages, there are a few possible explanations for results obtained in our study.
Gallated flavan-3-ol bioaccessibility was increased by addition of NFDM compared to
controls formulated with dd water, however no effect was found with regards to nongalloylated flavan-3-ols. This may be due to their greater extent of phenolic and hydroxyl
groups available for hydrophobic stacking and hydrogen bonding, respectively, with
intact

protein

and/or

peptides

by

galloylated

flavan-3-ols.

Enhancement

in

bioaccessibility of select tea flavan-3-ols by addition of NFDM suggest that proteins
present during digestion may be binding flavan-3-ols in the product and that these
interactions likely continue through initial portions of the digestion process. However,
following extensive digestion of protein, flavan-3-ols are released into the gut lumen.
Therefore interaction between specific milk proteins and green tea flavan-3-ols may
provide some level of protection for individual flavan-3-ols from oxidative degradation in
the upper small intestinal phase and increases availability for intact polyphenols to be
subsequently absorbed in the upper small intestinal epithelia (bioaccessibility). Increased
bioaccessibility may also translate to increased bioavailability as evidence exists to
support the notion that intestinal uptake may be altered by presence of protein. Addition
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of milk to green tea (69.3 mg/mL flavan-3-ols) to 25% in the formulation increased
flavan-3-ol transport across Caco-2 cell membranes compared to beverages formulated
with milk to 10% (Xie et al. 2012), and addition of milk protein (2.45 g) to cocoa
beverages containing 10 mg/mL cocoa polyhenols slightly accelerated flavan-3-ol
absorption in humans (Keogh et al. 2007).
Green tea beverages formulated with NFDM were also compared to those
formulated with milk minerals to gain insight into the impact of milk protein relative to
effects derived by interactions with just milk minerals (Figure 7, Table 10). Compared to
beverages formulated with milk minerals, NFDM significantly increased (p<0.05)
bioaccessibility of EGC, and decreased (p<0.05) bioaccessibilities of EC, EGCG, and
ECG, suggesting that interactions between galloylated flavan-3-ols and milk proteins
may be conserved during digestion, decreasing flavan-3-ol bioaccessibililty relative to
interactions with milk minerals in test beverages. However, this could also suggest that
milk mineral interactions may result in soluble complexes that are more stable during
digestion than milk protein interactions to better preserve stability of flavan-3-ols.
However, these results remain somewhat inconclusive as interactions between
milk minerals and protein (as with NFDM) may alter availability for both minerals and
proteins that would result in fewer milk mineral-flavan-3-ol interactions or flavan-3-olprotein interactions and by extension less flavan-3-ol stability through the GI tract. Also,
mineral presence is well known to alter protein structure. The impact of milk minerals on
casein structure has been extensively reviewed (Swaisgood; Fennema; Payens et al. 1979;
Rollema 1992; Shmidt 1980). Minerals, especially calcium, are required to impart
stability to the casein micelle. Studies have shown that changes in variations in mineral
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content and casein net charge alter casein structure (Ouanezar et al. 2012; Moitzi et al.
2011). In addition, studies show that minerals may modulate hydrophobic interactions
between whey proteins (Phillips et al. 1991), reduce their charge (Schmidt et al. 1978),
and aid in formation of whey protein gels (Schmidt et al. 1984). Thus, part of NFDM
effect is due to mineral presence. It is therefore likely that observations concerning
impact of NFDM proteins on flavan-3-ol bioaccessibility from green tea are more
accurate when the treatment is compared to matching controls containing milk minerals
than to those lacking milk minerals. Although significant differences in bioaccessibility
were found between NFDM treatment and buffer control beverages, differences were
modest (about 20, 15, 4, and 5% difference for EGC, EC, EGCG, and ECG, respectively)
and thus may not have significant physiological consequences (Figure A.1). Therefore,
while these data provide evidence of interactions and modulation of flavan-3-ol
bioaccessibility, it would generally agree with previous reports of the minimal impact of
milk on polyphenol bioavailability from tea beverages (van het Hof et al.1998; Hollman
et al. 2001; Kyle et al. 2007; Keough et al. 2007; Roura et al. 2007; Schramm et al.
2003 ).

4.3

Impact of Milk Minerals and Individual Milk Proteins on Bioaccessibility of
Flavan-3-ols from Green Tea Beverages

Differences in flavan-3-ol bioaccessibility from S-CSN/water compared to SCSN/JK beverages were investigated to better define the role of protein in presence and
absence of milk minerals. There appeared to be no overall effect of milk mineral buffer
on S-CSN-flavan-3-ol interactions under the conditions assessed. This may be due to
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outcompetition of flavan-3-ol-mineral interactions by strong interactions between S-CSN
and flavan-3-ols. The impact of S-CSN/water on flavan-3-ol bioaccessibility was greater
compared to milk minerals, supporting this notion (Figure 7).
To determine the impact of individual milk proteins, matching digestions were
completed with S-CSN, α-LA, and β-LG solubilized in either dd water or buffer at
concentrations reflecting those found in milk replacing NFDM in the formulations.
Results from these studies suggest that formulation of JK in place of dd water in green tea
beverages altered in vitro bioaccessibility of flavan-3-ols. Furthermore, JK contains salts
found in milk serum, and thus addition of proteins solubilized in buffer to green tea
beverages should allow for a more accurate assessment of how green tea flavan-3-ols and
proteins may interact in a milk system. Therefore, two key whey protein in milk (α-LA,
and β-LG) were solubilized in JK (1.0 and 3.5 mg/mL, respectively), formulated in green
tea beverages between 0.1-0.4 and 0.35-1.4 mg/mL, respectively,and digested in vitro.
Bioaccessibilities of flavan-3-ols from each type of beverage formulated with an
individual milk protein (S-CSN, α-LA, or β-LG) in JK, matching controls, and beverages
formulated with NFDM were then compared.
Addition of each individual protein into the final formulation affected
bioaccessibility of tea flavan-3-ols. S-CSN in JK significantly decreased bioaccessibility
of all flavan-3-ols compared to JK control (Figure 9, Table 10). The micellar structure of
casein is disrupted when converted to sodium caseinate and sub-micelle like structures
can be formed containing α-s1, α-s2, β, and κ-caseins at 4:1:4:1.3, with the bulk of nonpolar regions residing in an inner core and hydrophilic regions on the outer layer (Farrell
et al. 1990; Ruis 2007; Pitkowski et al. 2008). Binding of micellar casein and individual
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casein constituents to flavan-3-ols has been explored. Caseinomacropeptide was reported
to form complexes with green tea flavan-3-ols irrespective of pH (von Staszewski 2012).
Additionally, results following ultrafiltration of milk proteins with flavan-3-ols suggest βcasein (β-CSN) has high binding affinity and high binding capacity for EGCG compared
to β-LG. β-CSN may have a high affinity for EGCG due to presence of aromatic amino
acids and histidines in its structure (Bohin et al. 2012). Results from single molecule
force microscopy implied that β-CSN wraps around EGCG, becoming more stiff and
compact. The deformation of β-CSN around EGCG was entropic, indicating hydrophobic
interactions were the primary force of interaction. Additionally, no enthalpy effects were
observed, indicating hydrogen bonding is relatively weak in comparison to hydrophobic
interactions (Jöbstl et al. 2006). Another study confirmed through circular dichromism
and fluorescence spectroscopy that α- and β-CSNs interact with tea flavan-3-ols through
hydrophobic interactions between flavan-3-ol phenolic rings and hydrophobic pockets of
casein, altering protein structure resulting in protein unfolding. The authors also
suggested that intramolecular hydrogen bonds may tighten the casein structure around the
flavan-3-ol (Hasni et al. 2011).
Although the ability of various types of caseins to bind flavan-3-ols has been
demonstrated, it is not clear how sodium caseinate interacts with flavan-3-ols.
Furthermore, sodium caseinate is very susceptible to pepsin hydrolysis (Guo et al. 1995).
It was therefore suprising that these interactions both survived and had effects on ultimate
bioaccessibility of flavan-3-ols. To better explore this effect, digestion experiments were
designed to test interactions between intact EGCG and milk protein hydrolysates and will
be discussed in a later section.
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Interestingly, flavan-3-ol bioaccessibility was lower in green tea beverages
formulated with S-CSN compared to NFDM formulations. As mentioned above, the
structure of casein is significantly disrupted during production of sodium caseinate. On
the other hand, casein micelles are partly restored after reconstitution of NFDM (Sharma
et al. 1996). Therefore, due to differences in structures between sodium caseinate and
casein present in reconstituted NFDM, their potential for interactions with flavan-3-ols
may differ. The observed differences in flavan-3-ol bioaccessibility suggest that
interactions between sodium caseinate and GT flavan-3-ols may be greater than when
casein is present in a more natural state as from reconstituted NFDM or from fresh milk.
Therefore, formulation of products should begin to consider not just protein source but
form of the protein used if delivery of biologically relevant flavan-3-ols is a key aspect of
the product.
Interestingly, this notion was previously observed when comparing the impact of
milk and sodium caseinate-based nondairy creamer on bioavailability of phenolics
(Renouf et al. 2010). Compared to regular instant coffee, maximum plasma concentration
(Cmax) of chlorogenic acid and metabolites were significantly lower and time needed to
reach Cmax (Tmax) was significantly longer in coffee beverages formulated with nondairy
creamer. However, addition of milk to coffee beverages had no effect on phenolic Cmax
or Tmax, suggesting potential for fewer or weaker protein-phenol interactions. The
primary difference between milk and nondairy creamer is the structure of the casein
complex present in the system: milk contains colloidal casein, whereas nondairy creamer
typically contains sodium and/or calcium caseinate (Gardiner 1977; Buddemeyer 1980).
Similar to our study, it appears that sodium caseinate interacts with phenolics to a greater
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extent than casein present in natural micelles, ultimately delaying phenolic intestinal
absorption and altering parameters of bioavailability. Although the structure of sodium
caseinate is not clear, it can be postulated that more hydrophobic residues are exposed on
sodium caseinate compared to casein micelles, strengthening its interaction with flavan3-ols. As a result, release of flavan-3-ols from complexes with sodium caseinate may
occur later than from complexes with casein micelles, therefore increasing time to flavan3-ol uptake by small intestinal epithelial cells.
With regards to whey proteins, α-LA (assessed at 0.1-0.4 mg/mL) significantly
decreased (p<0.05) both relative and absolute bioaccessibility of both EGCG and ECG
compared to buffer control, but had no significant (p>0.05) impact on EGC or EC (Figure
9, Table 10). α-LA has a net negative charge at the pH of milk (pH 6.3-6.6) and folds
intramolecularly burying most hydrophobic residues (Swaisgood 1996). This structure
would conceivably make hydrophobic sites less available for interaction with phenolic
ring structures. Therefore with regards to binding interactions, hydrogen binding should
predominate between α-LA and gallated flavan-3-ols in an undigested state. However, αLA is rapidly degraded by pepsin (Fu et al. 2002). Thus, digested α-LA may expose
hydrophobic residues that may in turn associate with gallated flavan-3-ols through GI
digestion and result in reduced bioaccessibility.
Recent studies have explored specific interactions between α-LA and flavan-3-ols
using SDS-PAGE and particle size analysis (von Staszewski et al. 2011; Tantoush et al.
2012). At pH 4.5, (α-LA’s isoelectric point) incubation of whey protein concentrate
solutions (8% w/v in dd water) with green tea flavan-3-ols at 0.25% (w/v) for 24 hours
resulted in formation and precipitation of large α-LA-flavan-3-ol aggregates. On the other
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hand, incubation of the same solution at pH 6.0 generated smaller soluble complexes
requiring increased levels of polyphenol (1% w/v) for precipitation (von Staszewski et al.
2011). Another study showed that α-LA (1.0 mg/mL) remained in soluble portion of
solutions containing green tea flavan-3-ols (0.2 mg gallic acid equivalents per mL) after 5
minutes of incubation in acetate buffer (pH 4.5). However, α-LA was insoluble in
presence of oxidized green tea flavan-3-ols, suggesting rapid formation of insoluble
complexes between α-LA and oxidized green tea flavan-3-ols (Tantoush et al. 2012).
These results suggest that incubation conditions (time, pH) as well as oxidation state of
flavan-3-ols affect extent of flavan-3-ol-α-LA interactions. In the present study α-LA was
primarily exposed to pHs above and below its isoelectric point likely resulting in soluble
complexes between α-LA and flavan-3-ols, specifically favorable for gallated flavan-3ols (EGC, EGCG and ECG), explaining, in part, the effect of decreasing their
bioaccessibility.
Non-gallated flavan-3-ol (EC) relative and absolute bioaccessibility was not
significantly impacted by presence of α-LA in comparison to JK buffer control.
Previously, Prigent et al. (2009) reported low affinity of α-LA for EC using isothermal
titration calorimetry. It appears that gallation is important in binding between α-LA and
flavan-3-ols as it has been reported for other proteins including salivary proteins, casein
and albumins (de Freitas et al. 2001; Baxter et al. 1997; Xiao et al. 2011; Xu & Chen
2011; Soares et al. 2007). Over 10% of α-LA amino acid residues are aromatic
(Swaisgood 1996) making it plausible that hydrophobic stacking between galloyl groups
and aromatic amino acids may be central in α-LA-flavan-3-ol interactions as it is for
other proteins mention above. Similar to NFDM, although significant differences in
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individual flavan-3-ol bioaccessibility were observed between α-LA treatment and buffer
control beverages, it should be noted that these differences were less than 10% (Figure
A.2). Therefore, it is not expected that presence of α−LA would have significant impact
on bioavailability of flavan-3-ols from tea through binding interactions. The extent to
which formulation would drive oxidation and thus loss of absolute bioaccessibility should
be considered, however.
β-LG (0.35-1.4 mg/mL) decreased relative and absolute bioaccessibility of EC,
EGCG, and ECG compared to JK control (Figure 9, Table 10). As with other protein
interactions, this would be consistent with formation and preservation of β-LG-flavan-3ol associations during digestion. A recent study showed that β-LG complexed with green
tea flavan-3-ols, irrespective of pH (von Staszewski et al. 2012). Similar to α-LA, β-LG
(8% w/v) and polyphenols (0.25% w/v) interact at pH 4.5 forming large aggregates
resulting in precipitation of β-LG from whey protein concentrate. Smaller particles form
at pH 6.0, precipitating with addition of higher levels polyphenols (1% w/v) (von
Staszewski et al. 2011). Molecular modeling indicated EGCG-β-LG interactions occur
through H-bonding networks and hydrophobic interactions between flavan-3-ol phenolic
rings and hydrophobic pockets in β-LG (Kanakis et al. 2011). Similar modeling methods
suggest ECG-β-LG interactions occur through hydrogen bonding and van der Waals
interactions (Wu et al. 2011). Furthermore, structural analysis shows that more EGCG
binds to β-LG compared to other green tea flavan-3-ols, and ECG and EGC have the
lowest and highest binding constants, respectively (Kanakis et al. 2011). These
observations suggest that galloylated flavan-3-ols bind more readily to intact β-LG
compared to EC and EGC, consistent with our bioaccessibility results. This would, on
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the surface, suggest that binding in the product would be maintained through digestion
and impact availability for absorption.

Although significant, differences in individual

flavan-3-ol bioaccessibility found between β-LG treatment and buffer control beverages,
were moderate (about 20, 5, 5, and 6% difference for EGC, EC, EGCG, and ECG,
respectively) (Figure A.1). Therefore, as with other whey protein constituents, it is not
expected that these interactions would have significant impact on bioavailability of
flavan-3-ols from tea through binding interactions in the gut, but rather may drive some
changes in bioavailability through stabilization or destabilization of tea flavan-3-ols
through beverage formulation.

4.4

Protein Digestibility through Simulated GI Model

In order to confirm the extent of protein degradation by gastric and duodenal
digestion, we digested milk proteins to various extents and separated contents of resulting
digesta using SDS-PAGE analysis. S-CSN is susceptible to pepsin digestion (Guo et al.
1995) and α-LA is susceptible to pepsin and pancreatin digestion (Fu et al. 2002;
Tantoush et al. 2012) while β-LG is somewhat resistant to pepsin and trypsin digestion
(Guo et al. 1995; Tantoush et al. 2011). However, digestive conditions in the present
studies, including pH, combination of enzymes, and time are different than those used in
these previously published studies. Therefore, SDS-PAGE analysis was used to assess the
extent to which S-CSN, β-LG, and α-LA were digested in the in vitro digestion procedure
utilized for flavan-3-ol bioaccessibility studies.
After 1 hour of gastric digestion (G1) of S-CSN, bands resulting from separation of
undigested protein (G0) are almost fully digested to about half their original size (Figure
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10). Less dramatic effects were observed for β-LG and α-LA digests. β-LG G1
maintained similar protein profile compared to G0, however the level of the prominent
protein decreased. This partial resistance to pepsin digestion was previously observed by
another group (Guo et al. 1995; Tantoush et al. 2012). α-LA is a smaller protein with
molecular weight barely above the limit of separation for the specific gels used for
analysis. Therefore, there is very low resolution for the gastric phases, resulting in
formation of a dark band at the bottom of the gel for undigested α-LA and α-LA G1,
making it difficult to see any changes due to gastric digestion. However previous studies
suggest that rapid degradation of α-LA occurs in presence of pepsin (Fu et al. 2002;
Tantoush et al. 2012). For all protein digests, after 15 minutes of small intestinal
digestion (D15), protein bands present in G0 and G1 digesta disappeared, indicating that
peptides were broken down to <10 kDa rapidly from exposure to pancreatin during small
intestinal digestion (Figure 10). Based on previous studies, extensive pancreatic digestion
was expected for α-LA, but not β-LG (Fu et al. 2002; Tantoush et al. 2011, 2012). β-LG
may have been resistant to trypsin digestion (Tantoush et al. 2011) due to the very low
trypsin:protein ratio (1:100). However, pancreatin contains other proteolytic enzymes and
more accurately reflects the complexity of digestion in the human GI tract. Therefore
digestion would be expected in our current model. Also, concentrations of proteases used
in our studies were very high: 0.8 and 1.2mg/mL pepsin and pancreatin, respectively, in
final digesta. This is about 3x the concentration used in previous studies (Garrett et al.
2000).
Milk proteins appear to be partially degraded during gastric digestion and are rapidly
degraded to <10k Da during duodenal digestion at conditions used in our studies (Figure
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10). This information may help to explain the increased binding of flavan-3-ols to
proteins digested gastrically, and rapid decrease in binding of flavan-3-ols to proteins
digested duodenally.
The protein profile of digesta resulting from digestion of solely milk proteins may be
very different if digested in presence of flavan-3-ols. Studies have shown that flavan-3ols bind digestive enzymes, decreasing extent of protein degradation (He et al. 2006;
Nakai et al. 2005; Unno et al. 2009). For example, green and oolong tea polyphenols
decreased activity of digestive enzymes (He et al. 2006; Nakai et al. 2005; Naz et al.
2011). Therefore tea may alter protein digestibility and thus protein/peptide-flavan-3-ol
interactions during digestion.

4.5

Characterization of Milk Protein-EGCG Binding through Digestion

Considering the apparent limited impact of milk proteins on digestive
stability/release (bioaccessibility) of flavan-3-ols in our model system, the extent to
which binding interactions may be destabilized through digestion was explored. Prior
studies have investigated binding of intact flavan-3-ols to milk proteins. Evidence shows
that α- and β-CSN, α-LA, and β-LG all interact with flavan-3-ols with various binding
affinities (Almajano et al. 2007; Hasni et al. 2011; Kanakis et al. 2011; von Staszewski et
al. 2012; Bohin et al. 2012; Jöbstl et al. 2006; Tantoush et al. 2012; Prigent et al. 2009).
External quencher accessibility has been previously used as method to assess binding
interactions. This method tracks changes in fluorescence tryptophan (Trp) in intact
proteins. α- and β-casein contain two and one Trp residues, respectively on their surface
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(Kumosinski et al. 1993). Fluorescence spectroscopy was therefore utilized to estimate
flavan-3-ol binding through changes in protein Trp fluorescence.
S-CSN was chosen as the model to demonstrate changes in polyphenol-protein
binding throughout digestion because it is the most abundant protein in milk. EGCG was
chosen as the model flavan-3-ol because it is the most abundant polyphenol in green tea
and has high propensity for binding due to its abundance of galloyl and hydroxyl groups
available for hydrophobic interactions and hydrogen bonding. Fluorescence of protein in
presence of EGCG relative to its fluorescence without EGCG, %Fq, was calculated to
determine extent of quenching and by extension “binding” between intact protein or
peptides in digesta with EGCG. In the current study we investigated effect of gastric and
duodenal pH (pH 3.0 and 6.5, respectively) on flavan-3-ol binding to S-CSN and
contribution of Trp fluorescence quenched from background digestive enzymes (pepsin
and pancreatin). Finally, all conditions were combined (S-CSN digestion, pH, and
enzymes) to determine impact of the full system and compare to impact of each variable
(Figure 12).
Protein net charge and conformation change with pH thus altering location of
amino acid residues on their structure possibly affecting extent of protein-flavan-3-ol
binding. According to results, EGCG quenches significantly more (p<0.05) intact S-CSN
fluorescence at pH 6.5 compared to pH 3. Also quenching was significantly higher
(p<0.05) with intact enzyme fluorescence at pH 3.0 compared to 6.5 (Figure 12). This
may be due to repulsion between protein and EGCG near the protein’s isoelectric point or
due to unfavorable charged distribution or conformation of protein for London dipole
forces with EGCG. In agreement with aforementioned fluorometry results regarding the
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effect of protein digestion on milk protein-EGCG binding, it appears that protein
hydrolysis and conformation both are major factors contributing to binding interactions
with flavan-3-ols.
Another factor that may impact flavan-3-ol milk protein interactions during
digestion is presence of digestive enzymes. Studies have shown that flavan-3-ols interact
with digestive enzymes (He et al. 2006; Nakai et al. 2005; Tagliazucchi et al. 2005; Naz
et al. 2011). Flavan-3-ol-enzyme interactions may decrease available flavan-3-ols for
interaction with milk protein. Therefore, we assessed fluorescence quenching of Trp
residues from an enzyme cocktail containing pepsin and pancreatin at pH 3.0 and 6.5.
Results indicated that EGCG quenches enzyme Trp fluorescence at both pHs evaluated
(Figure 12). Thus, Trp fluorescence quenching observed in our system may be
attributable to binding of EGCG with both digestive enzymes and test protein. Unlike SCSN, however, it appears that enzymes interacted with EGCG to a significantly (p<0.05)
greater extent at pH 3.0 compared to pH 6.5. Therefore, binding in the duodenal phase
were most likely a result of residual interactions with peptides generated from digestion
of milk proteins.
An additional factor that may also impact flavan-3-ol binding to milk protein is
protein digestion. Intact protein is stabilized by hydrogen bonds and hydrophobic and van
der Waals interactions, with hydrophobic areas buried in the center of the molecule.
During gastric digestion, proteins are partially denatured by low pH and pepsin digestion.
Pepsin is an endopeptidase that hydrolyzes proteins into large peptides. It cleaves peptide
bonds preferentially at carboxyl groups of tyrosine, phenylalanine, or tryptophan residues,
and does not cleave peptide bonds linked to the imino group of proline. Trypsin and
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chymotrypsin are serine endopeptidases in pancreatin that are active during small
intestinal digestion. Trypsin preferentially cleaves peptide bonds with positively charged
residues, such as arginine or lysine, and proline inhibits cleavage by trypsin.
Chymotrypsin acts on bonds with large hydrophobic amino acid residues, such as
tryptophan, phenylalanine, tyrosine, methionine, or leucine, in addition to trypsin and
chymotrypsin. Pancreatin also contains a general protease, which cleaves peptide bonds
non-specifically (Moughan & Stevens 2013). As peptide bonds within protein are cleaved,
the structure unfolds uncovering buried polypeptide chains in a process termed
demasking (Adler-Nissen 1986). Consequently, amount of ionizable groups is increased,
and additional hydrophobic pockets may be exposed (Panyam & Kilara 1996; Vorob’ev,
2013) and likely made available for additional interactions with flavan-3-ols.
Furthermore, secondary and tertiary structure of the protein molecule is disrupted, and
surface topology and molecular flexibility are altered.
Studies have investigated the impact of milk protein hydrolysis by digestive
enzymes on protein structure. With regards to casein, tryptic hydrolysis resulted in
protein with lower molecular flexibility and higher α-helix and β-sheet (Wang et al.
2013). Furthermore, hydrophobic residues were increased and ionic residues were
decreased by both pepsin and pancreatic hydrolysis, resulting in attraction between
protein molecules (Su et al. 2008). Potential structural changes to these proteins induced
by digestion may therefore alter their ability to interact with flavan-3-ols. Specifically,
hydrophobic interactions, hydrogen binding, and van der Waals interactions (specifically
London forces) may be altered favoring additional binding. In general, it appears that
after one hour of gastric digestion, the extent to which S-CSN is digested enhances these
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interactions with flavan-3-ols (Figure 12). However, after duodenal digestion
protein/peptide degradation may be so extensive that potential for strong interactions with
flavan-3-ols is decreased. Therefore, while interaction during gastric digestion may be
strong, interactions decrease as protein digestion continues to generate small peptides and
amino acids during duodenal digestion. Subsequent to binding of protein to flavan-3-ol
before or during gastric phase, the time the interaction survives without release will
determine influence on flavan-3-ol bioaccessiblity: Release early in the duodenal phase
decreases protection and potential for flavan-3-ol interaction with digested protein;
release toward end of duodenal phase may increase bioaccessibility; and failure to release
may decrease bioaccessiblity. Consequently, bioavailability may be altered modestly.
Alternatively, interactions may delay uptake from small intestinal epithelium, increasing
Tmax of flavan-3-ols in plasma, an effect observed for plasma kinetics of chlorogenic acid
from coffee by addition of milk in the formulation (Reneuf et al. 2012).
In this study, S-CSN was digested enzymatically and gastric and duodenal
samples were pH adjusted to pH 3.0 or 6.5, respectively, before fluorometric analysis to
determine the impact of complete digesta environment on Trp fluorescence quenching by
EGCG. Results suggest that %Fq of S-CSN and digestive enzymes are not additive: Trp
fluorescence quenched by the whole system was significantly lower (p<0.05) at every
extent of S-CSN digestion compared to S-CSN incubated under the same conditions
without enzyme (Figure 12) at 0 and 1 hour of S-CSN gastric digestion compared to
enzyme incubated under the same conditions without S-CSN (Table C.4). Therefore,
binding between EGCG with S-CSN and digestive enzymes appears to be noncompetitive and non-specific. This suggests that EGCG binds aromatic amino acid
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residues besides Trp, and may even bind these residues with greater affinity. In addition,
there were no significant (p<0.05) differences between %Fq of each phase of S-CSN
digestion. Therefore, variations in fluorescence quenching of S-CSN and enzyme Trp
residues observed due to pH and extent of S-CSN digestion may mitigate differences in
binding of EGCG to protein/peptides throughout digestion.

Although binding is

occurring between EGCG and proteins in each digesta, it is hard to distinguish to what
extent the impact is due to S-CSN or digestive enzymes. By comparing fluorescence data
with SDS-PAGE data, it can be hypothesized that during the gastric phase of digestion,
S-CSN and its digestion products may bind EGCG appreciatively, however rapid
digestion of S-CSN during the duodenal phase may mitigate binding between S-CSN
digestion products. Therefore, binding that occurs during duodenal digestion may be
primarily attributable to interactions between digestive enzymes and EGCG.
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CHAPTER 5. CONCLUSIONS AND FUTURE WORK

5.1

Overall Conclusions

In the present study, bioaccessibility of individual tea flavan-3-ols appeared to be
affected by both presence and type of milk protein. Inclusion of S-CSN significantly
decreased (p<0.05) relative and absolute bioaccessibility of all flavan-3-ols, β-LG
significantly decreased (p<0.05) relative and absolute bioaccessibility of all flavan-3-ols
except EGC, and α-LA significantly decreased (p<0.05) relative and absolute
bioaccessibility of only gallated flavan-3-ols compared to buffer controls (Figure 9, Table
10). We attribute these digestive losses to protein-flavan-3-ol interactions that balance
both availability of flavan-3-ols for oxidative reactions in the gut environment and
solubility of flavan-3-ol-protein complexes. That being said, the impact α-LA and β-LG
had on flavan-3-ol bioaccessibility was moderate, while S-CSN had a greater impact.
This is consistent with the body of literature on binding interactions between individual
proteins and flavan-3-ols in model systems (Hasni et al. 2011; Kanakis et al. 2011; Bohin
et al. 2012; Arts et al. 2002; Lorenz et al. 2007; Shpigelman et al. 2012).
Perhaps most interesting, it appears that milk minerals may have more of an effect
on flavan-3-ol bioaccessibility than milk proteins themselves. Beverages formulated with
JK buffer containing milk minerals significantly increased (p<0.05) bioaccessiblity of all
flavan-3-ols compared to dd water control (Figure 7, Table 10). However, in presence
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of protein, milk minerals appear to lose their ability to affect flavan-3-ol bioaccessibility,
possibly due to loss of mineral-flavan-3-ol interactions to competition with mineralprotein interactions (Figure 9, Table 10).
Formation of flavan-3-ol-protein complexes appeared to be dependent on structure
of both flavan-3-ol and protein. According to structural analysis executed in previous
studies (Hasni et al. 2011; Kanakis et al. 2011; Jöbstl et al. 2006; Prigent et al. 2009; Wu
et al. 2011) typical interactions involved in complex formation include hydrophobic
interactions between phenolic rings of flavan-3-ols with aromatic amino acids and
hydrophobic pockets of protein and, to a lesser extent, hydrogen bonding and van der
Waals interactions, for example between hydroxyl groups of flavan-3-ols with protein.
These interactions may protect flavan-3-ols from oxidative degradation, or render them
insoluble in the gut. Protein that appears to have little or no affect on the bioaccessibility
of a polyphenol either does not bind well to the particular polyphenol, or their interaction
may be broken by proteases during gastric digestion.
SDS-PAGE results from digestion of milk proteins imply that proteins are degraded
by pepsin at concentrations used in this study: high molecular weight and low molecular
weight proteins are decreased and increased, respectively, after 1 hour of digestion by
pepsin (Figure 10).
The impact of pH on intact S-CSN-EGCG and of S-CSN degradation by pepsin and
pancreatin digestion on (poly)peptide-flavan-3-ol interactions was investigated to obtain
a more detailed picture of these interactions during digestion (Figure 12). According to
results, it appears that pH has the greatest impact on S-CSN-EGCG interactions (Figure
12, Table C.4): EGCG binds S-CSN to a significantly greater (p<0.05) extent at pH 6.5
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compared to pH 3.0. Pepsin and pancreatin also complexed with EGCG, however binding
occurred to a significantly greater (p<0.05) extent at pH 3.0 compared to pH 6.5. The
change in propensity of protein to bind EGCG with pH is most likely due to changes in
structure, amino acid distribution, and net charge of protein.
Although changes in protein-EGCG interactions occurred due to change in pH,
binding between EGCG and protein resulting from digestion of S-CSN to various extents
were not significantly different (p>0.05) from each other (Figure 12, Table C.4). This
indicates that combination of individual effects mitigates an overall change in proteinEGCG binding between different stages of digestion. Furthermore, although
protein/peptide-EGCG binding occurred, it is unclear to what extent these effects are due
to EGCG binding to digestive enzymes.
Taken together, in vitro digestion, fluorometry, and SDS-PAGE results suggest that
milk protein-flavan-3-ol interactions are (1) dependent upon structure of both protein and
polyphenol and (2) altered by gastrointestinal digestion. Therefore, interactions between
flavan-3-ols and individual milk proteins may alter available flavan-3-ol levels following
gastric digestion and delay absorption in the small intestine. Complexes appear to form
during the gastric phase, decreasing bioaccessibility of flavan-3-ols and possibly
protecting them from degradation by oxidative conditions. Subsequent degradation of
protein

during

duodenal

digestion

may

break

these

interactions,

increasing

bioaccessibility of intact flavan-3-ols, thus increasing levels available for absorption in
the small intestine. These interactions would be more prominent as the S-CSN content
increases. This would explain differences previously observed between bioavailability of
phenolics when formulated with S-CSN nondairy creamers compared to milk (Renouf et
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al. 2010).

In addition to information obtained by in vitro digestion regarding protein-

polyphenol interactions, it appears that milk minerals interactions merit further
investigation as these interaction may influence flavan-3-ol stability during digestion,
thereby increasing flavan-3-ol bioaccessibility.

5.2

Future Work

While results from experiments outlined in this thesis suggest that protein-flavan-3ol complexes may be present in the gut following consumption of green tea with milk
decreasing bioaccessibility of flavan-3-ols, the impact of these complexes with regards to
bioavailability needs to be elucidated. In vitro data obtained from a Caco-2 cell culture
model may clarify to what extent uptake, absorption, and metabolism of flavan-3-ols
from small intestinal epithelial cells is affected by interactions between digested proteins
with flavan-3-ols. In addition, colonic fermentation may be utilized to determine extent to
which protein-flavan-3-ol interactions may inhibit catabolism of flavan-3-ols by colonic
microflora to phenolic acids that may subsequently be absorbed into the blood stream
more efficiently than the flavan-3-ols themselves.
The protein profile of digesta resulting from digestion of solely milk proteins may
be very different if digested in presence of flavan-3-ols. Studies have shown that flavan3-ols bind digestive enzymes, decreasing extent of protein degradation (He et al. 2006;
Nakai et al. 2005; Unno et al. 2009). For example, intact and oxidized flavan-3-ols
increased and decreased pepsin activity, respectively (Tantoush et al. 2012). Therefore,
milk proteins should be digested in presence of flavan-3-ols, and the protein profile of the
digesta should be compared to digesta resulting from digestion of milk proteins digested
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without flavan-3-ols to determine the extent to which flavan-3-ols alter digestion of
proteins. Similarly, milk protein-flavan-3-ol digesta fluorescence can be compared to
fluorescence of milk protein digesta mixed with flavan-3-ol digesta to compare binding
of digested flavan-3-ols with milk protein digested with and without presence of flavan3-ols.
Bioactive milk peptides are released from milk proteins by digestive enzymes.
Some are resistant to further digestion (Reynolds et al. 1994), while others are broken
down further, sometimes to more active peptides (del Mar Contreras et al. 2013; Quirós
et al. 2009; Tavares et al. 2011). The impact of green tea flavan-3-ols on digestive release
and/or stability of bioactive peptides may be of interest. This could be achieved by either
1) amino acid sequencing to measure presence of established bioactive peptides, or 2)
measuring an indicator of disease prevention (angiotensin converting enzyme inhibition,
or markers of antithrombotic activity).
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Appendix A: Affect of Protein Concentration on Bioaccessibility of Green Tea Flavan-3ols in vivo.

Test solutions containing milk proteins were formulated to mimic concentrations
naturally occurring in milk (NFDM; α-LA, β-LG and S-CSN in buffer; S-CSN in water)
and formulated into green tea beverages at 10, 20, and 40%. There was no significant
concentration effect (p<0.05) at the three concentrations tested. Therefore we discussed
only beverages formulated to 40% with protein solution.
Although there was no significant difference (p>0.05) in flavan-3-ol
bioaccessibility from green tea beverages formulated with 10, 20, and 40% of test
material (p<0.05) (Figures A.1, A.2, A.3, A.4), it appears that relative and absolute
bioaccessibility of EGC from green tea beverages with formulated with 40% NFDM
formulations (71.89±1.36% and 141.57±2.68 μg/g) are higher than formulations
containing 10% of the test material (57.50±1.37% and 113.22±2.70 μg/g) (Figures A.1.
and A.3) In addition, it appears that relative and absolute bioaccessibility of EGC from
green tea beverages formulated to 40% with S-CSN (9.05±2.37% and 17.82±4.68 μg/g
for S-CSN in buffer, 6.84±1.01% and 13.48±1.98μg/g for S-CSN in water) are lower than
formulations formulated to 10% of the test material (22.55±2.65% and 44.40±5.22 μg/g
for S-CSN in buffer, 26.44±3.08% and 52.06±6.06 μg/g for S-CSN in water) (Figures
A.2 and A.4).
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Figure A. 5: Relative bioaccessibility (%) of EGC, EC, EGCG, and ECG from green tea
beverages formulated with (a) water, (b) buffer, and (c) nonfat dry milk.
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Figure A. 6: Relative bioaccessibility (%) of EGC, EC, EGCG, and ECG from green tea
beverages formulated with (a) α-lactalbumin, (b) β-lactoglobulin, and (c) sodium
caseinate in buffer, and (d) sodium caseinate in water.
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Figure A. 7: Absolute bioaccessibility (μg/g) of EGC, EC, EGCG, and ECG from green
tea beverages formulated with (a) water, (b) buffer, and (c) nonfat dry milk
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Figure A. 8: Absolute bioaccessibility (μg/g) of EGC, EC, EGCG, and ECG from green
tea beverages formulated with (a) α-lactalbumin, (b) β-lactoglobulin, and (c) sodium
caseinate in buffer, and (d) sodium caseinate in water.
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Appendix B: Protein Profiles of Raw Materials used for Digestions Preceding SDSPAGE and Fluorometric Analysis
kDa
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Figure B.2: Protein profiles of milk proteins and digestive enzymes used for digestions
preceding SDS-PAGE and fluorometric analysis.
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Appendix C: Fluorescence Quenching of Trp Residues by EGCG
The data shown in appendix B is select preliminary data (Table C.1 and C.2) and data
included in section 3.7 (Table C.3 and C.4), presented in table format. Method
development was initiated following a method by Kanakis et al. 2011. The fluorescence
spectra were obtained using λexc=280 nm and λemm from 290-500 nm and the intensity at
350 nm (tryptophan (Trp)) was recorded.
Preliminary tests showed that EGCG mixed 1:1 with Tris-HCl (buffer) fluoresced less
than just Tris-HCl (Table C.1). In addition, it appeared EGCG quenched digestive
enzyme fluorescence. Due to its low impact on fluorescence and ability to quench some
enzyme fluorescence, EGCG flurescence was not corrected for in calculations for percent
quenching of Trp residues by EGCG.
Table C. 3: Fluorescence Intensity of EGCG and Digestive Enzyme Cocktail

Sample

Average
Fluorescence

Tris-HCl

135.1 “ 1.60

Tris-HCl + EGCG

97.1 “ 1.05

Tris-HCl + Enzymes

404.1 “ 2.06

Enzymes + EGCG

307.1 “ 5.01

Fluorometric experiments were carried out on a Perkin-Elmer LS55 Spectrometer
(Woodbridge, ON, Canada). Method development was initiated following a method by
Kanakis et al. 2011. The fluorescence spectra were obtained using λexc=280 nm and λemm
from 290-500 nm and the intensity at 350nm (tryptophan (Trp)) was recorded.
Preliminary fluorometry results showed that both β-LG and enzyme cocktails elicit very
high fluorescent responses. After several tests, it was determined that responses of β-LG
solutions with concentration between 0.2-0.4 µM were within instrument’s linear range
of fluorescence. Literature on protein-polyphenol binding report protein:polyphenol
ratios (P:P) of 10:1 down to 1:27 (Hasni et a. 2011, Kanakis et al. 2011, Soares et al.
2007). Ratios ranging from 10:1 to 1:2 protein:polyphenol were tested keeping protein
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concentration constant (0.3 µM) and using EGCG as the model polyphenol, however the
noise was bigger than the change in response, making it difficult to guage the relative
extent of protein-polyphenol binding. Therefore, ratios ranging from 1:2 to 1:40
protein:polyphenol were assayed, again keeping protein concentration constant (0.3 µM).
For each subsequent decrease in milk protein:EGCG (MP:EGCG) at these levels,
fluorescence decreased, indicating that mixtures containing the aforementioned
MP:EGCG can be utilized to demonstrate the ability of EGCG to quench protein
fluorescence. The objective of this assessment is to determine binding of EGCG to native
and digested milk protein. Pepsin and pancreatin both contain Trp residues, thus the
amount of fluorescence they contribute to total protein fluorescence in digesta was a
concern. Therefore, 10-fold dilutions of enzyme cocktails containing pepsin and
pancreatin were assayed, starting at concentrations used for in vitro digestion of green tea
extract beverages (1.0 and 1.2 mg/mL, respectively), with and without β-LG. The
fluorescent response of cocktails containing 0.01 and 0.012 mg/mL pepsin and pancreatin,
respectively, was low in comparison to that of β-LG. The enzyme substrate ratio (E:S)
used for in vitro digestion of green tea extract beverages in this study was about 2:1.
Final digesta containing 0.5 µM milk protein and 0.01 mg/mL pepsin and 0.012 mg/mL
pancreatin, for E:S ratio of 2:1 was used to obtain a clear fluorometric response from
milk protein with little confounding fluorescence from digestive enzyme. According to
literature, this E:S is sufficient for the digestion of B-LG (Mandalari et al. 2009, Otte et al.
1997). Furthermore, a 12 µM solution of EGCG was prepared to be mixed 1:1 with
digesta for final MP:EGCG of 1:24 to force interactions between milk protein/peptides
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and EGCG so that hypotheses concerning the effect of protein digestion on proteinpolyphenol interactions can be made.
An EGCG stock solution (12 µM in Tris-HCl (10 mM, pH 7.4)) was prepared and
kept on ice for analysis. EGCG was stable under these conditions with 98% recovery
over 6 hr. S-CSN and β-LG digested to various extents in vitro were mixed 1:1 with
EGCG by inverting solution 10 times. EGCG and protein concentrations of each solution
were about 6 and 0.25 µM, respectively. Pepsin and pancreatin were also present from
background digestion enzyme mixes at 0.005 and 0.006 mg/mL, respectively, therefore,
blanks containing milk protein and background digestive enzyme mix mixed 1:1 with
Tris-HCl (pH 7.4) replacing EGCG (12 µM) were prepared. The fluorescence spectra
were obtained using λexc=280 nm and λemi from 290-500 nm. The intensity at 350 nm
(Trp) was recorded.

The percentage fluorescence quenched was calculated using the following
formula:

%Fq=[(F0-F)/F0]100
Where: F0= initial fluorescence intensity (intensity of blank)
F= fluorescence intensity in the presence of the quenching agent (intensity of
protein-EGCG solution)

The in vitro digestion procedure used prior to analysis by SDS-PAGE (outlined in
section (2.6.1) was used with minor modification to digest S-CSN and β-LG in
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preparation forfluorescence analysis. S-CSN and β-LG solutions (0.023 g/L and 0.035
g/L) were prepared in Tris-HCl (10 mM, adjusted with NaOH to pH 7.4). Final digesta
were normalized to half starting protein concentration, 0.005 mg/mL pepsin, and 0.006
mg/mL pancreatin and had final pH of 7.4. Gastric time zero (G0) samples were prepared
by addition of 1mL pepsin solution (0.07 mg/mL in 0.1M HCl) and 1 mL pancreatin
solution (0.084 mg/mL in 0.1 M NaHCO3) to 7 mL milk protein solution. G0 samples
were made up to 14 mL with Tris-HCl, pH adjusted to 7.4, nitrogen gas and frozen (20°C). For remaining samples, protein solutions (7mL) were pH adjusted to 3.0±0.1 (by
addition of 1 M HCl) and made up to 8 mL with saline. The gastric phase was initiated by
addition of 1mL pepsin solution (0.07 mg/mL in 0.1 M HCl). Pancreatin (1 mL, 0.084
mg/mL in 0.1 M NaHCO3) was added to gastric time zero (G0) samples which were then
made up to 14 mL with Tris-HCl, pH adjusted to 7.4, and frozen (-20°C). The duodenal
phase was initiated in remaining solutions by pH adjustment to 6.5±0.1 and addition of
1mL pancreatin (0.084 mg/mL in 0.1 M NaHCO3). Samples representing completed
gastric digestion (G1) were made up to 14 mL with Tris-HCl, pH adjusted to 7.4, and
frozen (-20°C). The pH of remaining samples was readjusted to pH 6.5±0.1. The
solutions were made up to 12 mL with saline, blanketed with nitrogen gas and incubated
in a shaking water bath (85 opm, 37°C). Digestions were stopped at either 15, 30, 60, or
120 mins (D15, D30, D60, D120), made up to 14 mL with Tris-HCl, pH adjusted to 7.4,
and frozen (-20°C).
The ability of select milk proteins to alter digestive stability and by extension
bioaccessibility of flavan-3-ols led us to further investigate the nature of EGCG binding
to intact protein and peptides resulting from various extents of digestion by fluorescence
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spectroscopy (Figure 11). EGCG was selected based on its abundance in tea and the high
likelihood of its association with individual milk proteins (Poncet- Legrand 2007; Hasni
et al. 2011; Baxter et al. 1997; Xiao et al. 2011; Xu & Chen 2011). This method assessed
the amount of Trp fluorescence quenched (%Fq) in individual protein by EGCG titration.
Proteins (β-LG and S-CSN) were prepared in Tris-HCl, digested to various extents by
pepsin and pancreatin at pH 3 and 6.5, respectively. The digesta were pH adjusted to 7.4
before analysis by fluorometry and mixed with EGCG solutions (pH 7.4). Final solutions
contained ~0.25 μM protein and ~6 μM EGCG. These levels were chosen based on
preliminary experiments that showed favorable concentrations for interactions between
milk protein/peptides and EGCG so that hypotheses concerning the effect of protein
digestion on protein-polyphenol interactions could be made without confounding
precipitation.
%Fq by EGCG was greatest for both β-LG and S-CSN gastric digesta (G1),
with %Fq of 13.23±0.90 and 12.39±1.06%, respectively (Figure 11). Furthermore, %Fq of
β-LG G1 by EGCG was significantly greater (p<0.05) than quenching of undigested
protein (6.67±0.65%) from each duodenal digesta. Specifically, %Fq of β-LG D15, D30,
D60, and D120 were 6.86±1.02, 3.18±0.72, 4.78±0.75, and 5.83±1.85% respectively.
However, %Fq of S-CSN G1 by EGCG was significantly greater (p<0.05) than only %Fq
of S-CSN G0 (5.83±1.0%) and S-CSN D120 (5.12±1.07%). Interestingly, %Fq of
undigested protein was not significantly different (p>0.05) for D15, D30, D60, and D120
digesta for both proteins. Additionally, EGCG quenched more fluorescence from S-CSN
peptides resulting from 15, 30, and 60 minutes of duodenal digestions compared to β-LG
peptides with 9.84±2.40, 5.79±0.22, and 8.15±1.01%Fq compared to 6.86±1.02,
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3.18±0.72, and 4.78±0.75%Fq, however this trend is not significant. Although %Fq of
undigested protein and duodenal digesta were low compared to G1 digesta, it appears that
some binding was still occurring.

Figure C. 1: Percent Trp fluorescence quenched by EGCG of S-CSN digested to various
extents. Digesta pH was adjusted to 7.4 and mixed 1:1 with Tris-HCl (pH 7.4) or EGCG
(pH 7.4, 12 μM) for analysis by fluorescence spectroscopy. The lightest area of the graph
corresponds with undigested protein, followed by protein digested gastrically, and protein
digested duodenally.
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Table C. 4: Percent Trp fluorescence quenched by EGCG of both β-LG and S-CSN
digested to various extents.

(a)

(b)

Extent of
Digestion

%Fq

Extent of
Digestion

%Fq

G0

6.67 ± 0.65

G0

5.83 ± 1.00

G1

13.23 ± 0.90

G1

12.39 ± 1.06

D15

6.86 ± 1.02

D15

9.84 ± 2.40

D30

3.19 ± 0.72

D30

5.79 ± 0.22

D60

4.78 ± 0.75

D60

8.15 ± 1.02

D120

5.83 ± 1.85

D120

5.12 ± 1.07
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Table C. 3: Trp fluorescence intensity of S-CSN solutions with and without EGCG.
Digesta pH and EGCG (12 μM) or Tris HCl were mixed 1:1 maintaining pH of digesta
for analysis by fluorescence spectroscopy. Each line is one of four different digestion
procedures: (1) S-CSN-EGCG binding effects due to digestive pH (gastric pH 3.0,
duodenal pH 6.5) (2) extent of binding between EGCG and digestive enzymes and (3)
combined effect of protein digestion, pH, and presence of enzymes in S-CSN digesta on
fluorescence quenching of protein Trp residues by EGCG. Superscript star denotes
significant difference (p<0.05) between sample with and without quencher.

Average Fluorescence Intensity at 350nm
Treatment

(1) S-CSN, no enzymes,
pH 3 and 6.5

(2) Enzymes,
pH 3 and 6.5

(3) S-CSN, enzymes,
pH 3 and 6.5

Extent of
Digestion
GpH0
GpH1
DpH15
DpH30
DpH60
DpH120
EG0
EG1
ED15
ED30
ED60
ED120
FG0
FG1
FD15
FD30
FD60
FD120

- Quencher

+ Quencher

393.01 ± 7.28
398.16 ± 1.66
451.73 ± 13.37
420.10 ± 6.65
429.60 ± 4.26
405.12 ± 6.75
225.16 ± 11.98
222.77 ± 9.09
317.85 ± 23.49
298.61 ± 45.21
251.78 ± 12.24
243.32 ± 7.85
463.12 ± 11.01
449.33 ± 5.36
598.30 ± 7.56
579.85 ± 6.21
559.94 ± 6.63
575.11 ± 8.78

275.43 ± 1.47 *
268.50 ± 2.79 *
278.67 ± 24.97 *
247.61 ± 8.30 *
260.17 ± 7.97 *
239.69 ± 2.91 *
182.13 ± 10.93 *
171.33 ± 6.35 *
280.12 ± 20.02 *
258.67 ± 40.62 *
207.01 ± 5.73 *
202.17 ± 6.29 *
402.56 ± 13.35 *
374.37 ± 6.04 *
507.44 ± 11.33 *
499.61 ± 9.06 *
482.08 ± 10.46 *
500.24 ± 8.96 *
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Table C.4: Percent Trp fluorescence quenched of S-CSN solutions by EGCG. Protein
solutions and EGCG (12 μM) or Tris HCl were mixed 1:1 for analysis by fluorescence
spectroscopy. Each line is one of four different procedures used to determine: (1) extent
of binding between EGCG and digestive enzymes (2) S-CSN-EGCG binding effects due
to digestive pH (gastric pH 3.0, duodenal pH 6.5) and (3) combined effect of protein
digestion, pH, and presence of enzymes in S-CSN digesta on fluorescence quenching of
protein Trp residues by EGCG. Different letters between treatments within a specific
extent of digestion denotes significant difference (p<0.05).

Extent of
Digestion
G0

G1

D15

D30

D60

D120

Treatment
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3
1
2
3

%Fq
19.18
29.83
13.06
23.01
32.57
16.69
14.76
42.61
15.18
13.56
41.09
13.85
16.02
39.45
13.91
16.96
40.77
14.45

±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±
±

1.10b
1.63a
2.36a
1.43b
0.48a
0.49a
1.57c
3.92b
1.60a
0.43c
1.39b
0.88a
0.84a
1.65b
1.41a
0.56a
1.50b
2.23a
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Appendix D: Acid Casein Technical Data Sheet

Figure D. 2 Technical Data Sheet for Acid Precipitated Casein
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Appendix E: Specific Methodology

Preparation of sodium caseinate
Stock Solutions
Acid precipitated casein
Tris-HCl (10 mM, pH 7.4)
1M NaOH
Procedure:
1. Prepare acid precipitated casein in Tris HCl
2. Adjust pH to 6.3 using 1M NaOH solution
3. Stir consistently for 2 hr using magnetic stir bar maintaining pH at 6.3 until
powder is completely dissolved
4. Store at 4°C for up to a week
In Vitro Digestion for Subsequent SDS-PAGE Analysis of Digesta

Stock Solutions
20 mg/mL pepsin in 0.1 M HCl
30 mg/mL pancreatin
0.9% saline
Procedure:
Gastric Phase
1. Place 14 mL tubes containing beverage (5.6 mL) on ice.
2. Bring up to about 8.4 mL by addition of 0.9% saline.
3. Adjust pH to 3.0 ± 0.1 using 1.0 M HCl. Record volume and pH.
4. Add 0.56 mL of pepsin solution to each tube.
5. Bring up to about 11 mL by addition of 0.9% saline.
6. Collect and freeze (-20°C) samples representing gastric time zero.
7. Blanket remaining samples with nitrogen gas, cap, parafilm.
8. Incubate in shaking water bath at (37°C, 85 opm,1 hr)
Intestinal Phase
1. Remove tubes from water bath and place on ice.
2. Freeze gastric digests representing 1 hour gastric digestion (-80°C) and freeze dry.
3. Add 1.0 M NaHCO3 to raise pH to 6.5 ± 0.1. Record volume and pH.
4. Add pancreatin solution (0.56 mL) to each tube.
5. Check pH and readjust if needed.
6. Bring up to 14 mL by addition of 0.9% saline.
7. Blanket with nitrogen gas, cap, and parafilm.
8. Incubate in shaking water bath at (37°C, 85 opm, ≤2 hr).
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9. Freeze samples representing various extents of duodenal digestion (-80°C) and
freeze dry.

SDS-PAGE analysis of sample digests
Stock Solutions:
Polyacrylamide gel
Tris-HCl (10 mM, pH 7.4)
Bio-Rad 2x Laemmli buffer
2% Coommassie Blue solution
Destaining solution (30% methanol, 10% acetic acid, 60% dd H2O
Molecular weight marker calibration kit
Procedure:
1. Resolubilize freeze-dried digest in Tris-HCl for about 8 mg/mL total test protein.
2. Mix samples 1:1 with Bio-Rad 2x Laemmli buffer for 42 μL total solution and
boil (5 minutes).
3. Load samples (40 μL) to gel and molecular weight ladder (10 μL) onto gel.
4. Run gel at 100V for about 1.5 hours.
5. Stain gel with Coomassie Blue solution (30 min).
6. Destain gel for 10 minutes in destain solution. Dispose of destain, and repeat 10
minute destain a few times. Continue to destain overnight or until gel background
is clear.
In Vitro Digestion for Subsequent Fluorometric Analysis of Digesta
Stock Solutions
0.07 mg/mL pepsin in 0.1M HCl
0.084 mg/mL pancreatin
0.9% saline
Tris-HCl (10 mM, pH 6.5 and 3.0)

Procedure:
Gastric Phase
1. Place 14 mL tubes containing beverage (7.0 mL) on ice.
2. For gastric time 0 samples (G0):
a. add pepsin solution (1 mL) and pancreatin solution (1 mL), bring up to 14
mL total with Tris-HCl (pH 3.0), pH adjust to 3.0, and freeze (-20°C).
3. For remaining samples:
a. Adjust pH to 3.0 ± 0.1 using 1.0 M HCl (record volume and pH) .
b. Bring beverage up to about 8 mL by addition of 0.9% saline.
c. Add 1 mL of the pepsin solution to each tube.
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d. Blanket with nitrogen gas, cap, parafilm.
e. Incubate in shaking water bath at (37°C, 85 opm, 1 hr)
Intestinal Phase
4. Remove tubes from water bath, place on ice
5. For gastric time 1 hr samples (G1):
a. Add pancreatin solution (1 mL), bring up to 14 mL total with Tris-HCl
(pH 3.0), pH adjust to 3.0, and freeze (-20°C).
6. For remaining samples:
a. Add 1.0 M NaHCO3 to raise pH to 6.5 ± 0.1 (record volume and pH).
b. Add pancreatin solution (1 mL) to each tube.
c. Check pH, and readjust if needed.
d. Bring up to 12 mL by addition of 0.9% saline.
e. Blanket with nitrogen gas, cap, and parafilm.
f. Incubate in shaking water bath at (37°C, 85 opm,≤2 hr).
g. Bring samples representing various extents of duodenal digestion to 14
mL with Tris-HCl pH 6.5, pH adjust to 6.5 if needed, and freeze (-20°C)

Fluorometric Analysis
Instrument:
Excitation wavelength:
Emmission wavelength:
Wavelength of interest (Trp):

Perkin-Elmer LS55 Spectrometer
280nm
290-500
350nm

Procedure:
1. Pipette sample and with either Tris-HCl or quencher into cuvette 1:1
2. Invert solution ten times
3. Wipe down cuvette with Kim Wipe
4. Place in fluorometer
5. Record fluorescence

